Podcasts about schedule ii

Episode 192: ADHD Treatment.  Jordan Redden (MSIV) explains the treatment of ADHD. Dr. Bustamante adds input about pharmacologic and non-pharmacologic treatments. Dr. Arreaza shares the how stimulants were discovered as the treatment for ADHD. Written by Jordan Redden, MSIV, Ross University School of Medicine. Comments and edits by Isabelo Bustamante, MD, and Hector Arreaza, MD. You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.Introduction.ADHD is a chronic neurodevelopmental condition characterized by inattention, impulsivity, and/or hyperactivity. While it's often diagnosed in childhood, symptoms can persist well in adulthood. The treatment for ADHD is multifaceted. It often includes medication, behavioral therapy, environmental modifications, and sometimes educational interventions which are especially effective in younger patients. Ongoing evaluation is needed during treatment. Treatment needs adjustments over time.Starting with medications: Stimulants are the most well-studied and effective pharmacologic treatment for ADHD. These include methylphenidate-based medications such as Ritalin, Concerta, and Focalin, and amphetamine-based options, like Adderall, Vyvanse, and Dexedrine. Discovery of stimulants for ADHD> Dr. Charles Bradley discovered stimulants as the treatment for ADHD around 1937. ADHD did not have a name at that time, but it was known that some children had behavioral problems related to poor attention and inability to control their impulses, but they were still intelligent. Dr. Bradley was a psychiatrist who was working in the Bradley Hospital (Rhode Island), he was studying these children and, as part of his experiments, they developed severe headaches. He gave “Benzedrine” (a decongestant) to his pediatric patients to treat severe headaches, and he discovered that Benzedrine improved academic performance and interest in school and improved disruptive behavior in some children.How do stimulants work.Stimulants work primarily by increasing dopamine and norepinephrine levels in the brain, which helps improve focus, attention span, and impulse control. They typically show a rapid onset of action and can lead to noticeable improvements within the first few days of use. Dosing is individualized and should start low with gradual titration. Side effects can include reduced appetite, insomnia, headaches, increased heart rate, and emotional lability.Types of stimulants. Stimulants come as short acting and long acting. They can come as a tablet, liquid, patch, or orally disintegrating tablet. After the discovery of Benzedrine as a possible treatment for ADHD, more research was done over the years, and Ritalin became the first FDA-approved medication for ADHD (1955). The list of medications may seem overwhelming, but there are only two types of stimulants used to treat ADHD: methylphenidate and amphetamine. Long-acting stimulant medications are often preferred for their consistent symptom control and lower potential for misuse. Vyvanse (lis-dexa-mfetamine) is a widely used long-acting amphetamine-based option. As a prodrug, it remains inactive until metabolized in the body, which results in a smoother onset and offset of action and may reduce the risk of abuse. This extended duration of effect can help patients maintain focus and regulate impulses throughout the day without the peaks and crashes sometimes seen with shorter-acting formulations. Of note, Vyvanse is also approved for Binge Eating Disorder. Many of these medications are Schedule II controlled substances, so to prescribe them you need a DEA license. Other long-acting options include Concerta, an extended-release methylphenidate, as well as extended-release versions of Adderall and Focalin. These are especially helpful for school-aged children who benefit from once-daily dosing, and for adults who need sustained attention during work or academic activities. The choice between short- and long-acting stimulants depends on individual response, side effect tolerance, and daily routine.For patients who cannot tolerate stimulants, or for those with contraindications such as a history of substance misuse or certain cardiac conditions, non-stimulant medications are an alternative. One of the most used is atomoxetine, which inhibits the presynaptic norepinephrine transporter (NET). This leads to increased levels of norepinephrine (and to a lesser extent dopamine). Guanfacine or clonidine are alpha-2A adrenergic receptor agonists that lead to reduced sympathetic outflow and enhanced prefrontal cortical function, improving attention and impulse control. These alpha agonists are particularly useful in younger children with significant hyperactivity or sleep disturbances.Non-pharmacologic treatments.Behavioral therapy before age 6 is the first choice, after that, medications are more effective than BH only, and as adults again you use CBT.Medication is often just one part of a broader treatment plan. Behavioral therapy, especially in children, plays a critical role. Parent-training programs, positive reinforcement systems, and structured routines can significantly improve functioning. And for adolescents and adults, cognitive-behavioral therapy (CBT) is particularly helpful. CBT can address issues like procrastination, time management, emotional regulation, and self-esteem which are areas that medication doesn't always touch.Using medications for ADHD can be faced with resistance by parents, and even children. There is stigma and misconceptions about mental health, there may be concerns about side effects, fear of addiction, negative past experiences, and some parents prefer to treat ADHD the “natural” way without medications or only with supplements. All those concerns are valid. Starting a medication for ADHD is the first line of treatment in children who are 6 years and older, but it requires a shared decision with parents and patients. Cardiac side effects are possible with stimulants. EKG may be needed before starting stimulants, but it is not required. Get a personal and family cardiac history, including a solid ROS. Benefits include control of current condition and treating comorbid conditions.The presentation of ADHD changes as the person goes through different stages of life. For example, you may have severe hyperactivity in your school years, but that hyperactivity improves during adolescence and impulsivity worsens. It varies among sexes too. Women tend to present as inattentive, and men tend to be more hyperactive. ADHD is often underdiagnosed in adults, yet it can significantly impact job performance, relationships, and mental health. In adults, we often use long-acting stimulants to minimize the potential for misuse. And psychotherapy, particularly CBT or executive functioning coaching, can be life-changing when combined with pharmacologic treatment. There are several populations where treatment must be tailored carefully such as pregnant patients, individuals with co-occurring anxiety or depression, and those with a history of substance use. For example, atomoxetine may be preferred in patients with a history of substance misuse. And in children with coexisting oppositional defiant disorder, combined behavioral and pharmacologic therapy is usually more effective than either approach alone.Comorbid conditions.Depression and anxiety can be comorbid, and they can also mimic ADHD. Consult your DSM-5 to clarify what you are treating, ADHD vs depression/anxiety.Treatment goes beyond the clinic. For school-aged children, we often work closely with schools to implement 504 plans or Individualized Education Programs (IEPs) that provide classroom accommodations. Adults may also benefit from workplace strategies like structured schedules, noise-reducing headphones, or even coaching support. Ongoing monitoring is absolutely essential. We assess side effects of medication, adherence, and symptom control. ***In children, we also monitor growth and sleep patterns. We often use validated rating scales, like the Vanderbilt questionnaire for children 6–12 (collect answers from two settings) or Conners questionnaires (collect from clinician, parents and teachers), to track progress. And shared decision-making with patients and families is key throughout the treatment process.To summarize, ADHD is a chronic but manageable condition. Effective treatment usually involves a combination of medication and behavioral interventions, tailored to the individual's needs. And early diagnosis and treatment can significantly improve quality of life academically, socially, and emotionally.Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________References:American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed., text rev. (DSM-5-TR). Washington, DC: American Psychiatric Association; 2022. CHADD (Children and Adults with Attention-Deficit/Hyperactivity Disorder). Understanding ADHD. Accessed May 2025. https://chadd.org National Institute for Health and Care Excellence (NICE). Attention Deficit Hyperactivity Disorder: Diagnosis and Management. NICE guideline [NG87]. Updated March 2018. Accessed May 2025. https://www.nice.org.uk/guidance/ng87 Pliszka SR; AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894–921. doi:10.1097/chi.0b013e318054e724 Subcommittee on Children and Adolescents with Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2019;144(4):e20192528. doi:10.1542/peds.2019-2528 Texas Children's Hospital. ADHD Provider Toolkit. Baylor College of Medicine. Accessed May 2025. https://www.bcm.edu Wolraich ML, Hagan JF Jr, Allan C, et al. Attention deficit hyperactivity disorder in children and adolescents: Overview of treatment and prognosis. UpToDate. Published 2024. Accessed May 2025.https://www.uptodate.comThe History of ADHD and Its Treatments, https://www.additudemag.com/history-of-adhd/Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/. 

Considering mail order pharmacy? I'm Annette Leonard of https://www.annetteleonard.com find me on Instagram https://www.instagram.com/theannetteleonard When I was researching this question, I found the 6-8 mail order pharmacies that I thought best fit my needs and developed a list of questions to call and ask each pharmacy. I put the answers in a spreadsheet to see things visually to be able to rate and rank the options. Prior to choosing a mail order pharmacy, think about what your deal breakers are: timeliness? shipping speed? My questions were: Do you auto-renew and send medications every 28 or 84 days? When a script is out of refills, do you contact my doctor for a new prescription? In enough time for my prescription not to lapse? What about Schedule II meds like Fentanyl and Norco that need a new prescription every time, do you fill those? How would you help me ensure there isn't a lapse between prescriptions? How long does it take for you to get me my meds? (best- and worst-case scenario) What's the upside of using your service? What's the downside of using your service? How do I transfer all my current prescriptions to you? How do you make that easy for me? When can I reach you? How do you contact me if there are problems or questions? Do you fill prescriptions in 30/60/90 increments? Anything else it would be helpful to know? These are the pharmacies I included in my research: Amazon, Select RX, BlinkHealth, and Wegman's. In the end, I didn't chose to use mail order. I found only one company who would send Schedule II meds, several told me that they were having availability issues with some of my medications, very few were reachable over the weekend and shipping took 7-10 days. What about you? Are you doing this? Right now I only investigated options that take insurance, but it might be worth doing an examination of the mail order companies that don't. Has this worked out for you? What company are you using? Why do/don't you use mail order pharmacy? I'm Annette Leonard of https://www.annetteleonard.com find me on Instagram https://www.instagram.com/theannetteleonard About a year ago my pharmacy closed. I was ill-equipped for how disruptive this change was going to be. From none of my prescriptions transferring over automatically, to the new pharmacy hours, to how poor their communication is, there are a myriad of ongoing hassles that have been so frustrating in ways that I don't think many of my peers can relate to or understand. I get one prescription by mail. It's made me wonder whether I should get all my perceptions by mail? I spent several months researching. I didn't have any knowledge about mail order pharmacy. For those of us on anything more than 2 meds a day, I think mail order is worth considering. Especially for those who have difficulty filling their pill box, it's worth knowing that there are ways for those to be auto-filled, pre-packaged, pre-dosed, pill packs. There are a lot of variables to consider from price and availability to shipping times and other considerations. I'll talk about my exploration in my next video. **I have a new mini-course I'm finishing about how to unlock the power of your next doctor appointment*** the first 50 people get FREE enrollment. Sign up here https://www.annetteleonard.com/waitlist This is the Chronic Wellness Podcast. I'm Annette Leonard, speaker, coach, and sick person who believes that my illnesses do not define me. If health is the absence of disease and wellness is the presence of wholeness, then no matter what your disease status, we can work toward your wellness, your wholeness. Whether or not you are ever "healthy" on paper, you can be well. Join me and others on the path back to wholeness at AnnetteLeonard.com. Whether you are a person experiencing chronic illness or are someone who loves or serves people with chronic illness I have great resources here on this channel or on my website for you.

The Department of Justice's Drug Enforcement Administration on May 20 officially published its notice of proposed rulemaking that, if finalized, would reschedule marijuana from a Schedule I controlled substance to Schedule III: https://www.regulations.gov/document/DEA-2024-0059-0001 The Biden Administration signaled its intent to move forward with such a proposal earlier this month, and the NPRM's publication formalized that effort. The DEA's proposal said moving marijuana from Schedule I to Schedule III under the Controlled Substances Act would be “consistent with the view of the Department of Health and Human Services (HHS) that marijuana has a currently accepted medical use, as well as HHS's views about marijuana's abuse potential and level of physical or psychological dependence.” That, ultimately, is the difference between the two scheduling levels, as previously reported. Schedule I drugs are defined in the Act as “drugs with no currently accepted medical use and a high potential for abuse.” Those include heroin, LSD, ecstasy and, at least for now, marijuana. Schedule II drugs, in the terms of the legislation, show “high potential for abuse, with use potentially leading to severe psychological or physical dependence,” and are considered dangerous. These include combination products with less than 15 milligrams of hydrocodone per dosage unit (Vicodin), cocaine, methamphetamine, methadone, fentanyl and more. Drugs classified under Schedule III, how DEA is looking to classify marijuana, are those “with a moderate to low potential for physical and psychological dependence,” and have a lower abuse potential than Schedule I and Schedule II drugs. Currently, these include products containing less than 90 milligrams of codeine per dosage unit, like Tylenol with codeine, as well as ketamine, anabolic steroids, testosterone and more. Typically, according to Brandon Wiseman, attorney and president of Trucksafe Consulting and guest for this week's Overdrive Radio podcast, Schedule III drugs “are still controlled in the sense that they require a prescription.” As such, having a Schedule III drug in your system is not necessarily a disqualifying factor in DOT drug testing. The driver must have a valid medical prescription for that drug, and the medical review officer (MRO) that validates the results of the drug test has to be comfortable that the use of that drug won't impact the driver's ability to safely operate a truck. “Some prescription drugs will inhibit a driver's ability to safely operate a truck,” Wiseman said in the podcast. “And so we just weed those drivers out. Those drivers aren't going to be physically qualified. They're not going to be able to get a med card, for example, to be able to operate.” Hear much more from Wiseman in the podcast, and read Matt Cole and Alex Lockie's reporting on the rescheduling subject via these links: Cole: https://www.overdriveonline.com/15676307 Lockie's early two-part feature: **https://www.overdriveonline.com/15670141 **https://www.overdriveonline.com/regulations/article/15670542/marijuana-legalization-trucking-and-the-future-of-drug-testing

PAIN⁠ @painnonprofit ⁠Founder Flindt Andersen and Jason LaChance sat down to discuss California Assembly Bill 3171, authored by Assemblywoman Esmeralda Soria to Hold Fentanyl Traffickers Accountable by increasing the punishment for selling more than 28 grams of fentanyl. It escalates the prison sentence from up to four years to up to 9. The bill is as follows: Existing law classifies controlled substances into 5 schedules and places the greatest restrictions and penalties on the use of those substances placed in Schedule I. Existing law classifies the drug fentanyl in Schedule II. Existing law makes possession of a controlled substance for the purposes of sale of the substance punishable by imprisonment in a county jail for a period of 2, 3, or 4 years. Existing law makes transportation and sales of a controlled substances punishable by imprisonment in a county jail for a period of 3, 4, or 5 years and transportation to a noncontiguous county within the state punishable by imprisonment in a county jail for a period of 3, 6, or 9 years. This bill would increase the above-described penalties, as specified, if the controlled substance involved was more than more than 28.35 grams of fentanyl, more than 28.35 grams of an analog of fentanyl, a substance containing more than 28.35 grams of fentanyl, or a substance containing more than 28.35 grams of an analog of fentanyl. By increasing the penalty for a crime, this bill would impose a state-mandated local program.The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.This bill would provide that no reimbursement is required by this act for a specified reason. Flindt Andersen and Jason LaChance discuss the following topics and more. We give created to Assemblyman Jim Patterson who has been behind and in support of many bills to combat fentanyl. 01:33 Will this bill have a large impact on the fentanyl crisis? 06:37 Flindt and Jason question why there isn't more resources going towards addiction recovery programs. 14:14 Are we in the "War On Recovery"? 23:02 Are politicians finally gaining a greater understanding of addiction? 29:09 For more on Parents & Addicts In Need: If you or a loved ones need our services, to follow on social media, the Don't Hide The Scars Podcast, to get involved, or to donate ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://linktr.ee/painnonprofit⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠For more on Flindt Andersen, to have him speak at your organization visit⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠https://www.flindtandersen.com/⁠ ⁠⁠⁠⁠⁠⁠ #wedorecover #growth #changeyourlife --- Send in a voice message: https://podcasters.spotify.com/pod/show/donthidethescars/message

Jesse, Morgan, and Toby are back together to discuss the improving environment for US cannabis stocks. This is the fifth consecutive week of gains and broad US cannabis benchmarks are up over 50% this year. The boys analyze and appreciate the recent run in cannabis stocks and discuss how the space has evolved since the HHS announcement. They review the top performers AYR and Trulieve and those that have lagged like TerrAscend and The Cannabist. The conversation evolves into how the set of catalysts may play out in 2024, and the risk of remaining Schedule I or being moved to Schedule II. The conversation concludes by debating whether the space is investable with the 280E tax burden. 

It isn't unheard of in Virginia for patients to go days without access to certain prescribed medications, if the order was written by a physician assistant. However, a petition to remove a regulatory requirement that members of the medical industry say is primarily responsible for the delays is being considered by the Virginia Board of Medicine during its next meeting in August. Submitted by the Virginia Academy of Physician Assistants this May, the petition aims to remove the requirement that a physician's name must be listed on prescriptions for Schedule II through Schedule V drugs written by a physician assistant...Article LinkSupport the show

FDA BLACK LABEL WARNING ON ADHD MEDS is an exploration and exposure of the hypocritical system that these so-called 'authorities' around mental disorders, medication and treatment have been trying to keep up... but it's all crumbling. The FDA has finally acknowledged ADHD drugs can cause addiction, even when used as prescribed. The agency is now requiring this information to be added to its black box warning on all stimulant drugs.According to Citizens Commission on Human Rights (CCHR), the FDA's label change regarding addiction is long overdue. The U.S. Drug Enforcement Administration (DEA) has categorized ADHD drugs as having a “high potential for abuse” (Schedule II) since 1971. Current DEA Schedule II drugs include such highly addictive drugs as morphine, oxycodone, and fentanyl. https://www.fda.gov/drugs/drug-safety-and-availability/fda-updating-warnings-improve-safe-use-prescription-stimulants-used-treat-adhd-and-other-conditions https://fox59.com/business/press-releases/ein-presswire/634134443/fda-finally-adds-addiction-to-black-box-warning-on-adhd-drugs/?fbclid=IwAR0M3g8DOuVUA1VrUR3wZ32v9tPZvEiOIuaUqiCDuH_BuI97-YeXeGHlsoE https://www.thefp.com/p/america-addicted-to-adderall-shortage?utm_source=post-email-title&publication_id=260347&post_id=128098935&isFreumail=true&utm_medium=email&fbclid=IwAR2oalr2uCDQCtnszhiiOL5dx_KzYSVbQTybd139UUshrIMue1k9G3BN-tI For more information on this podcast, please visit www.adhdisover.com

Why are different shaped gummy candies different schedules?! A spiritual sequel to "Eating a Decapitated Gummy Bear" This is a valentine's themed episode for all you lovers out there! If you are more curious about cannabis and sex, check out the wikipedia page for yourself! On the adderall shortage, this article really explains it best: ‘The worst it's ever been': mysterious US Adderall shortage puts ADHD patients at risk Check out/subscribe to the patreon for more fun and off-the wall stuff!

A Woodstock man has been sentenced to 20 years in prison after he was convicted of multiple assaults on his girlfriend as well as drug charges. Justin Cameron Finnegan, 22, was convicted of kidnapping, possession of Schedule II controlled substances, violating a family violence court order, family violence aggravated assault, false imprisonment, and other charges, the Cherokee County District Attorney's Office announced Thursday. Superior Court Chief Judge Ellen McElyea sentenced Finnegan on September 16, to 20 years in prison followed by 10 years on probation. Probation conditions include no contact with the victim or witnesses in the case, mental health and substance abuse assessments, completion of a family violence intervention program, no alcohol and drug use, and no firearms. Charges stem from multiple domestic violence incidents over the course of five months in 2021.   A Helen woman has been arrested after authorities say she stole all the contents of a mailbox from a northeast Cherokee County business, including customers' checks. Ashley Burgess is accused of taking all the mail from the mailbox at Longhorn's Sanitation on Franklin Goldmine Road near Cumming between March and May, according to an arrest warrant filed Oct. 18 by the Cherokee Sheriff's Office. The warrant says Gordon County sheriff's deputies, during a traffic stop, found her in possession of the mail, which included over 30 checks from customers and registration information for 10 of the company's vehicles. Burgess was booked in the Cherokee County jail early Dec. 1. She is charged with 44 felony counts of identity theft fraud. As of December 1, she remained in custody with bond set at $214,500.   Herschel Walker brought his Senate campaign to Woodstock Thursday, where he spoke to supporters on the importance of voting for him and strengthening the military. Over 100 people came to Black Rifle Coffee Company Thursday night to see Walker, U.S. Rep. Barry Loudermilk, Sen. Lindsey Graham and other speakers, according to local law enforcement at the event. Walker, a Republican who is running against Democratic incumbent Sen. Raphael Warnock, started by thanking God, his family and everyone for attending. He urged everyone to vote for him in the December 6 runoff election. Walker first spoke about the problems he said he sees with the military, revolving around issues of "wokeness," COVID-19 vaccines and the need to "support the men and women fighting for this country and strengthen the military." Other issues he said he wants to address if elected include addressing racism and critical race theory and "not seeing color," "respecting law enforcement," reducing crime, controlling borders and inflation, as well as "putting Georgia and America first." Bryce Leatherwood from Cherokee County has made it to the top eight on NBC's “The Voice.” Leatherwood was one of eight to move on to the next round from the Top 10 Live Playoffs this week. Three contestants will be eliminated next week.  Monday, Leatherwood performed Morgan Wallen's “Sand in My Boots,” and received enough votes to make the top seven and automatically advance. In the live shows, the top remaining artists compete against each other weekly during a live broadcast. In this round, the audience votes to “save” their favorite artists, rather than the coaches. You can watch Leatherwood's performance on YouTube. “The Voice” airs at 8 p.m. Eastern time Mondays and Tuesdays on NBC and Peacock TV.   Sequoyah senior Taylor Pecht was named a first-team All-American by MaxPreps on Tuesday, joining an elite group of 60 honorees from across the country. Pecht, a setter, made the All-American team as a first-team all-around player after helping lead the Chiefs to a 37-4 overall record, a 7-0 mark in Region 6AAAAAA and a Class AAAAAA state runner-up finish. She finished the season with 1,200 assists, 286 digs and 52 kills. As a three-time all-state setter, Pecht capped off her high school career with 4,657 total assists, along with 999 digs and 232 kills. She crossed the 4,000-assist mark this season at the Rally High tournament in Emerson. Pecht was one of five players from Georgia to be honored, along with Buford's Ashley Sturzoiu on the first team and Polly Cummings on the second team, and Pope teammates Sophie Harvey and Cooper Abney on the second team. Following the season, Pecht was also selected to the American Volleyball Coaches Association's All-America team alongside teammate and fellow senior Skylar Martin. Pecht was an honorable mention, while Martin, an LSU commit, earned first-team recognition with a team-best 588 digs. Pecht finished her four-year career at Sequoyah with a 162-13 overall record, including a 50-win campaign in 2021. She led a dangerous Chiefs offense and helped elevate her teammates.   Woodstock Arts is bringing a traditional German Christmas market to downtown Woodstock this weekend. Christkindl Market, part of Woodstock Arts' festival series, will start at 11 a.m. Sunday and is scheduled to be open until 6 p.m. at the Woodstock Arts Event Green. The market will be designed much like a traditional German Christmas market, with traditionally dressed carolers, food, activities for the whole family, local artists and crafters and a special performance from the cast of Woodstock Arts' “A Christmas Carol.” Activities include wreath making, gingerbread decorating, local music happening throughout the day and more. At the end of the evening there will be classic holiday shorts played on the Woodstock Arts LED Screen. All the Woodstock Arts festivals are free to attend. #CherokeeCounty #Georgia #LocalNews           -          -          -          -          -          -          The Cherokee Tribune Ledger Podcast is local news for Woodstock, Canton, and all of Cherokee County. Register Here for your essential digital news.             This podcast was produced and published for the Cherokee Tribune-Ledger and TribuneLedgerNews.com by BG Ad Group     For more information be sure to visit https://www.bgpodcastnetwork.com/    https://cuofga.org/   https://www.drakerealty.com/   https://www.esogrepair.com/           See omnystudio.com/listener for privacy information.

Rick Doblin is a a psychedelic-assisted psychotherapist and the visionary behind MAPS—the Multidisciplinary Association for Psychedelic Studies), a non-profit dedicated to “delivering global healing through psychedelic research.”  His research proves how psychedelics heal trauma.  Rick started studying the power of psychedelics as medicine just one year before the US government scheduled an emergency ban on psychedelics—and he has continued to work on the frontlines of advocacy for the return of this medicine ever since.  In this episode, you'll hear us talk about the need for deep healing in a society that's running on fumes. His words on PTSD and what's possible for even the most complicated of cases brings a depth of hope that anyone with trauma (big t or little) can drop shoulders after listening.  The long term effects measured by his clinical trials are there. The safety is there. The need is there. The only thing missing is the regulatory approval and the adaptation for certain psychedelics to move from Schedule I (the highest of offense) to Schedule II, which allows medical use.  We also cover the extremes, like balancing a sober life with the use of this medicine— because that's all it is, medicine—and combining it with therapy.   And we catch beautiful quotes like this one: “A lot of the people who are involved in substance abuse problems feel isolated and alone. Part of the antidote to that is to feel that you are connected to this magnificent adventure of billions of years that's produced life on earth, and to feel that there's this web of love that's underneath everything.” TRIGGER WARNING: This episode discusses suicide and suicidal ideation, and some people might find it disturbing. If you or someone you know is struggling with suicidal thoughts, please, contact your physician, go to your local ER, or call the suicide prevention hotline in your country. For the United States, the numbers are as follows:Call the National Suicide Prevention Lifeline at 800-273-TALK (8255), or message the Crisis Text Line at 741741. Both programs provide free, confidential support 24/7.For Cananda, the numbers are as follows:Call the Canada Suicie Prevention Service 1.833.456.4566, available 24/7/365 or Text the Crisis Text Line at 45645, available 4pm - midnight   WORKS: - founder and executive director of MAPs—the Multidisciplinary Association for Psychedelic Studies, which has “dedicated the last 36 years to changing the way people think of, talk about, and consume psychedelics through research, education, and advocacy.” - TED: The Future of Psychedelic-Assisted Research TOOLS: - Research that sheds light on the true safety psychedelics can provide in healing trauma - Profound insights and data that open us up to what's happening when our minds are on psychedelics  - Reminders of the power therapy has and why I always always recommend it - Insight into the studies MAPS is conducting to better understand the profound effects this medicine creates - Discussions around the equity and accessibility of these tools and what changes have to happen   LAND ACKNOWLEDGEMENT:
BETTER is recorded on the unceded and ancestral territory of the hən̓q̓əmin̓əm̓ and Sḵwx̱wú7mesh speaking peoples, the xʷməθkʷəy̓əm (Musqueam), Sḵwx̱wú7mesh (Squamish), and səlilwətaɬ (Tsleil-Waututh) Nations, and has been stewarded by them since time immemorial.  BETTER with Mark Brand is produced by Pamela Rothenberg of I HEAR YOU STUDIOS and Adam Karch with Orbyt Media

Happy weekend! In this week's episode we finally put the partisan primaries in the rear-view mirror, we talk about Joe Cunningham's struggle to find a female running-mate of color and end with the criminal proceedings that Alex Murdaugh associate Curtis Edward Smith is currently facing.Krystle Matthews won the democratic run-off and is now the party's nominee to run for U.S. Senate. Before voters went to the polls, investigative news outlet Project Veritas published an audio recording of a conversation between Matthews and an inmate at the Perry Correctional Institution in which she suggests financing her campaign with “dope money.” Listen to the call in the episode or read my piece for further context.School choice advocate Ellen Weaver won 64 percent of the vote against Kathy Maness in the hotly contested Republican state school superintendent primary.Former U.S. congressman Joe Cunningham – the newly minted Democratic nominee for governor of South Carolina – is desperately seeking a black female candidate to serve as his 2022 lieutenant gubernatorial nominee.The problem? His first choice for the job – state senator Mia McLeod – told him “hell to the no,” according to sources familiar with the search process. George Amos Tenney III, 35, of Anderson, pleaded guilty in the District of Columbia to civil disorder and obstruction of an official proceeding for his actions during the breach of the U.S. Capitol on Jan. 6, 2021.In the episode I discuss Tenney's future and the potential for further escalation of political violence should this kind of behavior continue to be tolerated by both major political parties.We then give you a brief update on Tiger King star Doc Antle‘s indictments by a federal grand jury.Finally, we cover the new charges that Alex Murdaugh and his longtime friend and alleged co-conspirator Curtis Edward Smith face.The state grand jury has charged the pair with two conspiracy counts, including a narcotics count related to manufacturing and distribution of Oxycodone.Smith was also indicted on four counts of money laundering, three counts of forgery, trafficking methamphetamine 10-28 grams, one count of unlawful possession of a Schedule II controlled substance and possession of marijuana. More specifically, Smith is accused of cashing at least $2.4 Million dollars in checks — 437 of them! — over the course of eight years on behalf of Murdaugh.

A federal jury in Alabama convicted Xiulu Ruan and several other pain management physicians of running a medical practice constituting a racketeering enterprise in violation of several federal statutes, including provisions of the Controlled Substances Act. Ruan allegedly prescribed medicines, including Schedule II drugs (many of which are opioids), outside the standard of care for his practice. At trial, prosecutors showed that Ruan and other physicians in his practice prescribed medications for their own financial gain rather than for the benefit of their patients. Ruan and other defendants challenged their convictions, and the U.S. Court of Appeals for the Eleventh Circuit affirmed. The case was decided on June 27, 2022. The Court held that : Section 841's “knowingly or intentionally” mens rea applies to the statute's “except as authorized” clause. Once a defendant meets the burden of producing evidence that his or her conduct was “authorized,” the Government must prove beyond a reasonable doubt that the defendant knowingly or intentionally acted in an unauthorized manner. Justice Breyer delivered the opinion of the Court, in which Chief Justice Roberts and Justices Sotomayor, Kagan, Gorsuch, and Kavanaugh joined. Justice Alito filed an opinion concurring in the judgment, in which Justice Thomas joined, and in which Justice Barrett joined as to Parts 1–A, 1–B, and 2. Credit: Oyez, LII Supreme Court Resources, Justia Supreme Court Center, available at: https://www.oyez.org/cases/2021/20-1410 --- Support this podcast: https://anchor.fm/scotus-opinions/support

On this episode with Gary Roberts of Good Dudes Grow Podcast, hear Dr. Rocco discuss the power of marijuana in the medical field. Marijuana is an alternative to narcotics, which keeps chronically ill patients from becoming dependent on any Schedule II drugs.   Dr Thomas Rocco is a Medical Director of a medical marijuana evaluation center licensed by the Rhode Island Department of Health and physician at BAK 2 Basics CBD Medical Consultants.  Krystle MacDonald is part of the medical staff at BAK 2 Basics CBD Medical Consultants and has worked in the medical field with chronic pain patients for over six years.  She also worked at a licensed Medical Marijuana Evaluation Center in RI as an educator and consultant.  Krystle has experienced first hand the benefits of CBD, and is passionate about educating and helping others experience a natural alternative for relief.  She has created petition proposals to the State of Rhode Island to improve the RI Medical Marijuana Program. Contacts for BAK 2 Basics CBD Medical Consultants are Dr Thomas Rocco and Krystle MacDonald email- customerservice@bak2basicsllc.com phone- (401) 678-6420 website- https://www.bak2basicsllc.com/ website CBD Health- https://bak2basicsllc.com/about-us/education/blog/ SHOP QUALITY TESTED CBD PRODUCTS- https://www.bak2basicsllc.com/products/ Contact us for any medical CBD questions by email, text or phone call. Proper medical CBD therapy is our passion.  Get CBD from an MD #getCBDfromanMD #CBDphysician #CBDdoc #CBDHealthPodcast #Bak2BasicsCBD #CBD #hemp #mmj Please subscribe to our podcast. Thank you.

What if, instead of being prescribed narcotics to manage chronic pain, patients were given a holistic alternative? Dr. Thomas Rocco is here today to answer that question–and many more. Dr. Thomas Rocco is currently the Medical Director of a Medical Marijuana Evaluation Center, the only licensed and approved facility in Rhode Island for patient evaluation and education for medical marijuana. His work emphasizes safe and proper medical marijuana use for patients' chronic illnesses. He also works to use medical marijuana in hospice care to increase end-of-life comfort and peace. He completed his undergraduate studies at The Johns Hopkins University and obtained his medical degree while attending University Health Sciences/Chicago Medical School. He has also completed many certifications in surgery–basically, he's a rockstar.  On this episode of Good Dudes Grow, hear Dr. Rocco discuss the power of marijuana in the medical field. Marijuana is an alternative to narcotics, which keeps chronically ill patients from becoming dependent on any Schedule II drugs. He's here to explain their trailblazing journey, and get you excited about the future for the Evaluation Center. Tune in for an episode full of science, experience, and real results.    What You'll Learn:  How the Evaluation Center got their license  What Dr. Rocco does with CBD to help kids that come into the Center Why Dr. Rocco suggests his patients take their prescription CBD during the day, and THC at night And so much more!   Favorite Quote:  “We are tasked with doing it right. We're a resource for patients, other doctors, you name it. With this program, we're a pillar for the community.” Dr. Thomas Rocco   How to Get Involved:  You can find Bak 2 Basics on their website, Twitter, Instagram, YouTube, and Facebook. Gary Roberts is the founder and CEO of Pure Body Zen, a company based around creating and selling high-quality CBD products that work to heal mind and body alike. Gary considers hemp-based medicine a calling, and his organization, along with the world-class team that runs it, reflects his passion. You can learn more about Pure Body Zen on their site, on LinkedIn and on Instagram. If you enjoyed this episode, don't forget to visit the show on Apple Podcasts and leave a rating and review! We love hearing from you! -- We bring unbiased content from opposing views to give you nothing but the facts about Hemp CBD and Cannabis. Helping people understand the benefits of Hemp CBD and Cannabis, removing the fear of the unknown, and dispelling myths and presenting facts. Are you unsure about Hemp-Derived CBD and Cannabis but are interested in learning more about the benefits of this alternative solution to big pharma? We will step out into the unknown to have a clear understanding of what is and isn't possible with Hemp CBD and Cannabis through success stories about health, business and more.

Good Morning Veterans, Family, and Friends, welcome back to the TWENTY-FOURTH EPISODE of the Veteran Doctor. On this week's episode, we will discuss Veterans PTSD – The Cannabis Cure. Marijuana Use for PTSD Among Veterans The use of Marijuana for medical conditions is an issue of growing concern. Many Veterans use marijuana to reduce symptoms of PTSD, and many states specifically approve medical marijuana for PTSD. However, research has not been conducted on the safety or effectiveness of medical marijuana for PTSD. There is no evidence currently that suggests marijuana is an effective treatment for PTSD. This research indicates that marijuana can be harmful to individuals with PTSD. Epidemiology Marijuana use has increased over the past decade. In 2013, a study found that 19.8 million people reported using marijuana in the past month, with 8.1 million using it almost every day (1). Daily use has increased by 60% in the prior decade (1). Several factors are connected with increased risk of marijuana use, involving diagnosis of PTSD (2), social anxiety disorder (3), other substance use, mainly through youth (4), and peer substance abuse (5). Cannabis Use Disorders among Veterans Using VA Health Care There have currently been no studies of marijuana use conducted on the overall Veteran population. The data we have gathered comes from Veterans using VA health care, who may not represent the Veteran population overall. When considering this subset of veterans seen in the VA health care with co-existent of substance use disorders (SUD) and PTSD, cannabis use disorder has been the most diagnosed SUD since 2009. Veterans in the VA with PTSD and SUD diagnosed with cannabis use disorder increased from 13.0% in FY 2002 to 22.7% in FY 2014. As of FY 2014, more than 40,000 Veterans with PTSD and SUD are seen in VA diagnosed with cannabis use disorder. People in 33 States can use medical Marijuana. Why Haven't Veterans Been able to Use It for PTSD? Dogs have been prescribed medical marijuana, but veterans still cannot get the drug from the Veterans Affairs. Several Veterans groups are working on getting medical marijuana approved as a form of treatment for PTSD. The Department of Veterans Affairs (VA) still refuses to provide marijuana to veterans because it is listed as a Schedule I drug. Many Veterans groups want to get that designation changed and have more research conducted on the benefits of medical marijuana. Doug Distaso served his nation in the United States Air Force for 21 years. He had the opportunity to command joint aviation, maintenance, and support personnel globally and served as the primary legislative affairs lead for two U.S. Special Operations Command leaders. However, after an Air Force plane accident left Distaso with a traumatic brain injury, post-traumatic stress disorder (PTSD), and chronic pain, he was given more than a dozen prescription medications by doctors at the VA. "I was taking everything from opioids, antidepressants, benzodiazepines, and sleeping pills," Distaso stated. "Like countless other veterans, the cocktail of drugs that I was prescribed quickly threw my life into a turmoil, affecting my ability to perform at work, while straining my relationships at home." Distaso states that living his life in a prescription drug-induced, zombie-like state left his wife and family begging with him on Christmas morning to come back to them. "What brought me back to my family and career was medical cannabis. Cannabis helped me get off the pills and regain control of every facet of my life," Distaso said. Unfortunately, for millions of veterans who depend solely on their VA healthcare benefits, federal law ties their VA doctors' hands. It harshly denies these veterans access to needed medical cannabis as a treatment option. Distaso currently works for his fellow veterans as the Veterans Cannabis Project founder, which advocates for veterans' cannabis access, education to policymakers, and support for veterans seeking treatment options beyond the opiates and other prescriptive and addictive drugs they obtain from the VA. It is time for Congress to approve the VA to research the effects of cannabis on familiar veterans' health issues and allow doctors at the VA to recommend and assist veterans in accessing medical cannabis. The VA denial of cannabis Cannabis use is still branded as harmful to veterans on the VA's website. "Cannabis use for medical disorders is an issue of growing concern," the VA states. Cannabis also remains on the Schedule I list under the Controlled Substances Act, the same as heroin. According to the VA website, "measured studies have not been fully conducted to evaluate the safety or effectiveness of medical marijuana for PTSD. Thus, no proper evidence that marijuana is an effective treatment for PTSD has been collected." Conversely, the tide has turned nationally in terms of the attitude toward marijuana, especially for medicinal purposes. Despite the unattainability of medicinal marijuana at the VA, veterans nationally are using cannabis to deal with their PTSD symptoms of anxiety, depression, and chronic pain. Recent scientific studies are showing the medicinal properties of cannabis. The VA website downplays the approval of marijuana in the United States, stating that "several" states have accepted the use of medical marijuana and/or recreational marijuana. In all actuality, it's far more than "several." Thirty-three states have enacted medical marijuana laws that allow eligible people to obtain or grow cannabis to treat various conditions. Additionally, 15 states have decriminalized marijuana, and 11 states have legalized recreational marijuana. A recent poll conducted at Politico and Harvard's T.H. Chan School of Public Health shows that Americans feel that marijuana is much less harmful than alcohol, tobacco, or e-cigarettes. In the survey, one in five Americans state they believe marijuana is very harmful to people. Twice as many stated the same about alcohol, 52 percent characterized e-cigarettes as very toxic, and 80 percent indicated tobacco cigarettes are hazardous. And more than six in ten U.S. adults said they favor changing federal law to legalize marijuana for recreational use. Another recent survey shows strong majority support among Americans for legalizing marijuana. Also, almost all Democratic presidential candidates agree to remove marijuana from the federal list of controlled substances. And veterans and the American public overwhelmingly support medicinal cannabis for veterans. In the 2017 American Legion survey, 92 percent of veterans said they supported research into the use of medical cannabis, and 83 percent support legalizing medical cannabis. A new study on PTSD and cannabis A new study concludes that cannabis may already be helping Canadians cope with depression and suicide in people suffering from PTSD. This study was conducted on more than 24,000 Canadians, which concluded that people experiencing PTSD and not medicating with cannabis are far more likely to suffer from severe depression and have suicidal thoughts than those who used cannabis over the past year. The study provides initial evidence that cannabis use may contribute to decreasing the connection between PTSD, severe depressive, and suicidal states. This research states that there are limited treatment options for PTSD, so many patients have acted by medicating with cannabis to alleviate their symptoms. However, this is the first time that outcomes from a nationwide survey have exposed the potential benefits of treating the disorder with cannabis. This research documented the first relationships between PTSD, cannabis use, and severe mental health outcomes in the veteran population. The big question is: If a Canadian health survey looked at PTSD and cannabis with such a convincing conclusion, where is the VA on this issue, which affects as many as thirty percent of the American veterans who served in the wars since September 2001? Veterans group supports medical cannabis While the VA still stands on the statement that it is not allowed to do research; however, this is not actually true. They just have to coordinate with outside agencies to conduct it. Only one-third of veterans mentioned cannabis to their doctor because of the stigma attached to marijuana use. Veterans have a legitimate fear of reprisals at VA and in the workforce, where there have been programs that they can lose their jobs for testing positive for marijuana. We have found that in different parts of the country where the use of cannabis is less stigmatized open conversation can be conducted with the VA physicians. However, in parts of the country where it is still illegal, providers are more skeptical or judgmental. It shuts the veteran up and is then dangerous as the veterans do not communicate openly with their provider. Why the VA will not budge The biggest hurdle for veterans seeking cannabis from the VA is that it is still on that Schedule I list of controlled substances at the federal level. This means that cannabis "no acceptable medical use and has a more significant potential for abuse and risk for arrest," as identified by the federal government. The VA considers any form of marijuana illegal. This means veterans cannot get help accessing medical marijuana from their VA doctors, relying on their own means to obtain any. The recent congressional hearing explored bills that would allow for extended access to medical marijuana for veterans. VA representatives confirmed their position opposing any policies as long as marijuana remained illegal at the federal level. Many agencies are "committed to improving treatment options for veterans and supports research into potential treatment options that may prove valuable." Specific federal law restricts the VA's research with Schedule I controlled substances, including marijuana. Before conducting any VA research using a Schedule, I controlled substance would involve lengthy communications and coordination with the Drug Enforcement Administration (DEA), Food and Drug Administration (FDA), National Institutes of Health, National Institute on Drug Abuse, and the Health and Human Services. Particular requirements include reviewing an investigational new drug application and approval of the research protocol by the FD, obtaining the medical drug through NIDA and the nationally approved medical marijuana production laboratory, and an investigator registration and site licensure by the DEA. These restrictions that are contained in federal law are clear. Research is allowed but must be done with the identified federal entities. If Congress wants more federal research into Schedule I controlled substances such as marijuana, it can eliminate these restrictions. Multiple sources explain that Congress and the President can reschedule marijuana to make it accessible to veterans and make it researchable by the VA. Former VA secretary wants more research The Former VA secretary says that the VA should study cannabis. "It is a little bit strange that marijuana is Schedule I while cocaine is Schedule II," stated the former VA secretary. "To say there is completely no medicinal value or application in cannabinoids is not true at all." "There is already an FDA-approved drug on the market, which is a cannabinoid, to treat pediatric epilepsy." The FDA approved Epidiolex in June 2018; the first drug derived in the U.S. from the cannabis plant to reach local pharmacies. He added that when he ran the VA, he was told the agency could not discuss cannabis with veterans and could not do research. But he discovered later that this was not true. "We can talk to our veterans about it. We just cannot prescribe the cannabis," says the former VA Secretary. "It is possible to do research at the VA, but the barriers and bureaucracy are lengthy and painful. I can now more effectively articulate that Congress is the most likely player to streamline this research. And yes, it needs to be done." Medical marijuana research The Center for Medicinal Cannabis Research (CMCR) is the nation's oldest research center for the safety and efficacy of cannabis. CMCR recently announced research to explore the effectiveness and safety of medical cannabis as an alternative treatment for schizophrenia, insomnia, alcohol dependence, rheumatoid arthritis, and anxiety linked to anorexia. Research done by the CMCR has also shown that cannabis can be useful for relieving pain, but research has not been conducted for studying cannabis concerning PTSD. This center is directly linked to the VA's regional office located in San Diego. The legislation is not moving Certain Congress members have tried to push for new legislation to make medical marijuana available to veterans at the VA without success. Here are a few bills that have not made any progress: 1) The Veterans Equal Access Act allows the VA health providers to recommend medical marijuana to their veteran patients and provide the required paperwork to enroll in state marijuana programs. 2) The VA Medicinal Cannabis Research Act of 2018 supports the scientific and medical research of medicinal cannabis for veterans diagnosed with TBI, PTSD, chronic pain, and other injuries by clarifying that research of medicinal cannabis is within the authority of the VA. 3) The Veterans Medical Marijuana, Safe Harbor Act is an act that would enable VA physicians to issue medical cannabis recommendations under the laws of states where medical cannabis is legal. 4) The Safe Harbor Act would require the VA to conduct studies on the effects of medical marijuana on veterans in pain related to their treatment programs involving medical marijuana approved by states, veterans' access to these programs, and a reduction in veteran opioid abuse. OK, for dogs but not veterans? It is ridiculous that Americans in most states now have access to medicinal marijuana, but America's veterans do not. I have a non-veteran friend, and he receives medical marijuana for his dog's anxiety. He was shocked when he discovered that dogs could get medicinal marijuana, but veterans cannot get the same treatment at the VA. Washington, D.C. is an echo chamber of circular logic. We are convinced there is a national craving for this issue on medical cannabis for veterans. Still, politicians only seem to hear themselves and continue to assume that there is not. We must change this view and make it known. Cannabis May Help Veterans With PTSD After 17 years in the military and deploying to almost every terrorist filled location on Earth, former Green Beret Adam Smith discovered that while his combat battles had ended, his personal one still lingered. "I had a hard time with anxiety, sleeping, hyper-vigilance, and symptoms that revolve around PTSD," Smith, remembering his difficult transition to civilian life, starting in 2015. "I found myself hopeless and in an awful place," said Smith, who also suffers from the effects of several past brain injuries. "The bottom of this black hole was me sitting on a couch with a pistol in my mouth." Thankfully, Smith did not go through with it and said that in the years since, what's helped sustain him is the lessened joint pain, better sleep, and moderated his constant sensation of always feeling "switched-on," has been … self-medicating with cannabis. Smith is just the kind of veteran lawmaker that is trying to help with two U.S. House bills that approved at the House Committee of Veterans Affairs on March 12: H.R. 712, the VA Medicinal Cannabis Research Act of 2019, directing the Veterans Administration to research marijuana's impact on physical conditions related to active duty. H.R. 1647, the Veterans Equal Access Act of 2019, allows physicians to complete state-legal medical marijuana proposal paperwork due to VA doctors currently being prohibited from doing this, forcing veterans to turn to private-network physicians. Irritatingly Smith states, "When it comes to veterans and veterans' rights, the game of politics should not exist." Smith has publicly talked about his avoidance of Veterans Administration treatment because of its chosen response to suffering veterans. That response includes treating veterans' symptoms with anxiety meds, sleeping pills, and high blood pressure meds and does not necessarily treat the total patient. Smith finally realized in 2015 when he tried marijuana for the first time, alongside a military buddy who said marijuana had sharply reduced his seizures and improved his sleep. This may not display hard evidence to support cannabis as a solution for PTSD; many veterans swear by it. Post-traumatic stress is no joke; Post-traumatic stress is something that's hitting our community in an epidemic. The social answer to deal with the trauma is to drink and drug our way into distraction or sedation, so we do not have to feel the pain anymore. That should not be the methodology." Many Americans agree. A recent poll of 5,369 U.S. adults found support for CBD treatment, with 53 percent of those polled agreeing that medical dispensaries should be considered an "essential service." What seems here like a cultural shift may have as much to do with the current anxiety engendered by the coronavirus crisis (which has spiked cannabis sales) as it does the different sort of pain veterans and first responders experience. Marijuana is a top treatment for veterans' pain, PTSD, but the cost is a barrier According to recent survey data, military veterans are using cannabis to treat chronic pain, post-traumatic stress disorder, anxiety, and depression, among other ailments. But the cost of medical marijuana is a barrier since it is not covered by insurance, even though veterans are using cannabis as an alternative to pharmaceuticals. Final results from the 2019 Veterans Health and Medical Cannabis Study, which looked at 201 veterans in Massachusetts and 565 respondents nationwide, were presented at the Cannabis Advancement Series. The study, which was performed March 3 through Dec. 31, was conducted by Marion McNabb, Steven White, Stephen Mandile, and Ann Brum. Over half of the 201 Massachusetts veterans who completed the survey through outreach by veterans' groups, marijuana dispensaries, and social media sites were age 50 or older. Most, 54 percent had served in the Army. The sample was overwhelmingly male, 90 percent and 84 percent were white, non-Hispanic. Chronic pain, anxiety, and PTSD are the top medical conditions facing veterans. Nearly one in three, 30 percent, of the veteran participants, were currently or homeless in the past. Ninety-one percent of participants reported using medical marijuana. Recreational marijuana was used by 59 percent. Results from 2019 Veterans Health and Medical Cannabis Study Top health conditions Massachusetts veterans are facing As reported by 201 Massachusetts survey participants in the 2019 Veterans Health and Medical Cannabis Study 37% Chronic pain 25% PTSD 10% Anxiety Primary health conditions Massachusetts veterans find cannabis most helpful for treating 36% Chronic pain 24% PTSD 11% Anxiety 6% Depression Top barriers to accessing cannabis reported by Massachusetts veterans 55% Money to purchase prod money 37% Money required to get a medical card 33% Access to the right products 33% Stigma 26% Owning a firearm 21% Workplace testing or other policies Massachusetts veterans report cannabis allows them to: 89% Experience a much better quality of life 79% Experience much less psychological symptoms 69% Experience much less physical symptoms 44% Use alcohol much less now 40% Use prior medication (non-opioid) much less now 23% Use tobacco much less now 22% Use opioids much less now Many veterans responded to the survey reporting that cannabis provided relief for their primary medical troubles, and 77% said that they were actively trying to reduce the use of their over-the-counter or prescription medications with medical cannabis. The top symptoms being treated with medical cannabis included: pain, 51 percent; sleep problems, 50 percent; depression or mood, 45 percent; anxiety or panic attacks, 41 percent; and aggression, 24 percent. "It surprised me, but it is not that surprising," McNabb stated. "They are consumers of medical cannabis. They are finding relief in medical cannabis." The survey's findings brought additional attention to previously published research on medical marijuana by Staci Gruber. Gruber stated that almost all research on the impact of cannabis on the brain and cognitive functioning comes from recreational users, most of whom began using the drug as teenagers while their brains were still developing. Studies conducted by Gruber have found that after three months of treatment, medical marijuana patients demonstrated an improvement in task performance accompanied by changes in brain activation patterns measured in imaging. Further, after treatment, brain activation patterns appeared more similar to those in healthy controls, who weren't using marijuana than pretreatment with medical marijuana. Gruber said her research suggested that medical marijuana use may affect the brain differently compared to the brain impacts among recreational marijuana users. Consistent with the veterans' survey, Gruber's study also found medical marijuana patients reported improvements in how they felt and notably decreased their use of prescription drugs, predominantly opioid and benzodiazepines, after three months of treatment. Mandile became an advocate for medical marijuana after being seriously wounded in Iraq while deployed in 2005. His Veterans Affairs doctors put him on 57 medications, which included nine opioids. In 2013 he attempted suicide. In 2014, his wife's ultimate goal for Mandile was to wean himself from prescription drugs by using marijuana, which he accomplished in only five months. He formed a nonprofit organization called the Alternative Treatment for Veterans to advance awareness of medical marijuana and work with dispensaries to offer discounts to veterans who have been rated 100 percent disabled by the VA. The product 11 marijuana dispensaries across the state have picked up the product discounts testified on proposed legislation, H. 4274, that would allow veterans to use their VA paperwork to qualify for a medical marijuana card instead of paying hundreds of dollars for the state-required card. The 2017 state law legalizing the adult-use of marijuana called for the Cannabis Advisory Board to make recommendations to the Cannabis Control Commission on related costs associated with the purchase of medical marijuana by U.S. military veterans insured through the VA, and to make recommendations on improving cost-effective access. But the study and recommendations were never made by the Sept. 2018 deadline, Mandile said. "As much as legislators can feel the connection with anecdotal stories," Mandile said, "they needed something more concrete, more data-driven." This data found Massachusetts veterans spending an average of $79 a week on cannabis. Nearly three-quarters, 72 percent, purchase cannabis from regulated dispensaries, while one out of five, 19 percent, grow their money The money to purchase marijuana products and get a medical marijuana card was the top two topics reported in the veterans' survey. DAV - The Cannabis Cure DAV requests more research on medical cannabis as an alternative treatment for veterans with chronic pain, PTSD, and TBIs Like many veterans, military service rigors have taken a toll on Air Force veteran Jarid Watson's body. He is not sure when the injury occurred—perhaps during the 12 years of physical training or while loading and unloading cargo planes—but at some point, the ball joint of his hip tore his labrum and damaged the surrounding cartilage. The injury brought on Watson's chronic pain and eventually led to his medical retirement in 2016. It also severely affected his sleep, which negatively influenced his motivation and mood. As a father, husband, student, and entrepreneur, something had to be done to fight this pain and restore being able to achieve a good night's rest to restore himself, his family, career, and studies. For Watson, there was only one choice. "As soon as I knew my military career was ending and dealing with this chronic pain was in my future, I considered medical cannabis as an option because I'm not going to take pain pills and potentially get addicted.' Watson's reluctance toward pain pills stems from his personal experience. As a native of northeast Ohio, the Afghanistan War veteran lost two close friends to opioid overdoses and has witnessed how addiction can destroy individuals and their families. "That area has been devastated with opiate and heroin use. That is tearing families apart in this country. It is killing people," Watson said. The National Center for Health Statistics released a report in 2017 stating that there was a national opioid crisis killing more than 42,000 Americans in 2016. Alarmingly, a 2013 analysis by the Center for Investigative Reporting found that opioid prescriptions for veterans spiked 270 percent over 12 years, while a 2011 Department of Veterans Affairs study found that veterans were twice as likely to die as compared to the rest of the population from an opioid overdose. The VA also estimates that 68,000 veterans, 13 % of the total veteran population currently taking opioids, have an opioid-use disorder. According to VA officials, doctors continue to prescribe them for chronic pain, a condition that 60 percent of veterans sustained from deployments to the Middle East and 50 percent of older veterans. "Sixty percent of what the VA treats falls into the category of chronic pain, and the VA system is not designed to do much more than push pills, and those pills are not working," said Nick Etten, founder and executive director of Veterans Cannabis Project. The story of Air Force veterans Jarid and Priscilla Watson helps display the effectiveness of medical cannabis. Jarid uses medical cannabis to help treat his chronic hip pain rather than using opioids pharmaceuticals, which he feels are dangerous. "He's much happier, more productive, and more motivated in his everyday life," said Priscilla, noting the difference. Etten, a former Navy SEAL, also noted that medicinal cannabis is an effective treatment for the wounds he sustained in the Middle East—PTSD and TBI. He named pain, sleep, and anxiety as the primary symptoms veterans deal with concerning their service-connected injuries. "Cannabis is proving to be safe and effective in treating my injuries," he said. "That's where it can be transformative and a potential game-changer." "Before cannabis, he was constantly complaining about how tense he was and how much pain he had," said Watson's wife, Priscilla. "His pain would keep him up all night, so he would be exhausted, tired, and need naps throughout the next day. But now, he sleeps all night and is not in pain anymore." As an Air Force veteran and nutritional therapist herself, Priscilla feels cannabis is a more natural and safer alternative to attending to his pain than opioid pharmaceuticals, noting the disparity between what she calls "the obsolete argument that marijuana is dangerous." "He is happier, more productive, and more motivated," she added. "So, it has changed his quality of life greatly." Medical cannabis's benefits associate with its responsible use, including refraining from driving while under the influence and ensuring that proper dosage is administered. "As someone with a nutrition background, I do not let Jarid smoke it because I do not like having to deal with the damaging effects of the smoke in the lungs," she said. "He uses cannabis in the form of edibles, which I think is a lot safer, and tends to produce a more positive effect." While the VA cannot deny any veterans benefits due to medical marijuana use, the VA providers cannot recommend or prescribe any form of cannabis since the Food and Drug Administration still classifies it as a Schedule I drug. Instead, Veterans must pay out of pocket for an annual physician's evaluation and medical cannabis cards in one of 30 states, which have legalized medical marijuana. Participation in any state marijuana program does not affect a veteran's eligibility for VA care and services. VA providers can discuss cannabis use with veteran patients and adjust care and treatment plans as needed. However, Etten adds that the federal classification of cannabis leaves many veterans in limbo. While some can afford to pay the out-of-pocket costs, many others cannot and must rely solely on the VA for health care. Until cannabis has been removed from the Schedule I list and elevated from a health policy issue where it can be treated as a medical treatment, we will be stuck in this legal gray zone where we are currently located. However, the federal government maintains that more research into the efficacy of medical marijuana needs to be conducted before it is declassified and made available to service-connected disabled veterans through the VA. DAV Resolution #23 supports additional research in the use of medical cannabis, noting the DAV's call for more research—rather than just legalization—requiring the need to know more about both the potential benefits and risks associated with medical marijuana. As veterans, we do not want to prescribe a new form of treatment without research showing it is safe and effective. The VA Medicinal Cannabis Research Act of 2018 promotes the scientific and medical research into the safety and efficiency of medicinal cannabis usage on veterans diagnosed with PTSD, TBI, chronic pain, and other injuries by clarifying that research medicinal cannabis is well under the authority of the VA. "We have heard of veterans who use cannabis medicinally to cope with physical and mental injuries sustained from active service for our country," said Walz. "Twenty-two percent report using cannabis as a safer and more effective alternative to opioids and drug cocktails currently prescribed by VA for the medical conditions such as PTSD or chronic pain." "As a physician, I am acutely aware of the need to look for opioid alternatives to treat patients' chronic pain," said Roe. "I've heard from many veterans who suffer from physical and invisible wounds and believe medical cannabis could benefit them." The Veterans Medical Marijuana Safe Harbor Act (S. 3409) would also empower VA physicians to issue medical cannabis recommendations under states' laws where it is legal. This legislation would also force the VA to conduct studies on "the effects of medical marijuana on veterans in PTSD and pain" and "the relationship between treatment programs involving medical marijuana that are approved by States and a reduction in opioid abuse among veterans." In 2014 a study by the Journal of the American Medical Association discovered that medical marijuana laws had a twenty-five percent lower average annual opioid overdose death rate than states without such laws. "If veterans can ease some of their chronic pain, symptoms of injuries they have received from serving their country without turning to opioids, the VA has a responsibility to research it," said Sen. Jon Tester. Despite the criticisms of medical cannabis use, as it becomes gradually accepted, no other demographic stands to benefit more from its use and legality as America's veterans. "I was tentative at first to be open about it because of the stigma that is still associated with cannabis," said Watson. "However, ultimately, you finally realize how much it helps, and you feel guilty for not sharing that information with everyone else." Veterans organizations like DAV are precisely what medical cannabis users need to advocate for making medical cannabis an available alternative for veterans everywhere. References: Bonn-Miller, M. & Rousseau, G. (2015). Marijuana Use and PTSD Among Veterans. Department of Veteran Affairs. Retrieved from https://www.ptsd.va.gov/professional/treat/cooccurring/marijuana_ptsd_vets.asp Hunter, T. (2018). A Cannabis Cure. Disabled American Veterans (DAV). Retrieved from by https://www.dav.org/learn-more/news/2018/the-cannabis-cure/ Oleck, J. (2020). Cannabis May Help Veterans With PTSD. And Lawmakers May Be Acknowledging That. Forbes. Retrieved from https://www.forbes.com/sites/joanoleck/2020/03/30/cannabis-may-help-veterans-with-ptsd-and-lawmakers-may-be-acknowledging-that/?sh=79ecf8315fe6 Reno, J. (2019). People in 33 States Can Use Medical Marijuana. Why Can't Veterans Get It for PTSD? Healthline. Retrieved from https://www.healthline.com/health-news/why-are-veterans-still-being-denied-cannabis-for-ptsd-treatment Spenser, S. (2020). Marijuana is a top treatment for veterans' pain, PTSD, but the cost is a barrier. The Metro West Daily News. Retrieved from https://www.metrowestdailynews.com/news/20200204/marijuana-is-top-treatment-for-veterans-pain-ptsd-but-cost-is-barrier

Cannabis is more than just THC and CBD. Today Ryan Heath, owner of Shady Oak Hemp Farm, returns to dispel the many misconceptions that still surround cannabis today, despite the growing trend toward legalization and recent move to the UN's Schedule II drug list. Ryan begins by breaking down the difference between CBD and THC, the painstakingly detailed process of farming cannabis, and the experience of smoking versus ingesting. He talks about narrowing down why you are using marijuana (pain relief, panic attacks, winding down), so that you can choose the best strain to meet your needs and optimize your experience, and answers questions about the effectiveness of recent topical CBD creams. Ryan chats with Chris and Vanessa about the versatility of cannabis, its rejuvenating effect on soil, and why it is a true art form. They end with an informative conversation about issues with dosing, the importance of quality over quantity in the cannabis game, and exciting new strains of cannabinoids to come. Today's episode is sure to leave you with a better understanding of the process, purpose, and power of the cannabis plant in general. Thanks for tuning in.   The Finer Details of This Episode: Ryan's experience growing, trimming, laboring, consuming cannabis Trend toward legalizing marijuana and amending it to Schedule II drug list CBD (cannabidiol) and THC (tetrahydrocannabinol) are the most common cannabinoids found in cannabis products THC is the main substance that people think of when they think of getting stoned CBD doesn't cause that high, but instead works with other elements in the body to bring wellbeing and balance Misconceptions about CBD - how it works, what it does, and the many different ailments it can help with Hemp oil does not have any CBD in it Incredible amount of work that goes into farming cannabis - everything is done by hand Smoking versus ingesting Pro tip to swish tincture (liquid cannabis) in your mouth for better absorption Narrowing down what you are using the product for  Indica is generally best for pain relief Topical CBD creams are transdermal, similar to a nicotine patch Creams are marketed for pain relief, but research is lacking on whether it's actually anti-inflammatory Cannabis is not stronger today - it's just being grown better and to its full potential It is also a full-use crop, where no part is thrown away Also rejuvenates and replenishes the soil Quality over quantity in the cannabis game Ryan recently had his hemp made into oil using Good Land Extracts  Ryan chose which strains to grow based on harvest schedules CBG is a new strain of cannabinoid, as well as THCV (appetite suppressant) and THCZ (helpful for diabetics) Quotes: “THC is the one that's intoxicating, that's the one that gets you the high effect. That's the one that most people would say is fun.” “CBD is calming, but there's no market value there.” “We planted about 15,000 single plants. And each one came down by hand, and hauled in by hand, and hung up by hand, and each bud taken off by hand.” “It's such a delicate plant that you can't mess with it too much.” “To a horticulturist, they're just - they're kind of like a wet dream.” “Once it's out of the field, you're only about halfway there… You've got to get every single little bud off each plant.” “When you're inhaling through your lungs, all those cannabinoids hit your bloodstream instantly - the minute it hits your lungs.” “Indicas are generally known for pain relief.” “People don't know that, Hey, you can actually smoke CBD and that might be a better way of getting it in you.” “THC is a much more powerful cannabinoid than CBD.” “[Cannabis] is not stronger. We're just letting it grow to its full potential now.” “The reality is, this plant is a damn piece of art. It can do so many things.” “It literally pulls the bad stuff out of the soil, and doesn't put it into the flower somehow. It just sticks it in the stock. So none of that negative stuff gets into the consumable product. It makes the land better.” “Hemp is unlike any crop. Quantity does not necessarily mean profit. Quality means profit… Quality is number one in the cannabis game.” “To make any sort of good cannabis, lots of positive energy has to go into that. If it's not put in there, it's a bad product and it's just not going to work as well.”   Show Links: Out of the Common homepage

Is Joe Biden Helping Big Pharma on Marijuana Legalization? (Schedule II) --- Send in a voice message: https://anchor.fm/lmc-cannabis-news-podcast/message Support this podcast: https://anchor.fm/lmc-cannabis-news-podcast/support

The Hon'ble Supreme Court had taken up this issue earlier in the year 2017 and upon years of deliberation and consultation, “Draft Rules of Criminal Practice, 2020” was formulated. Accordingly, to the Court, such Rules are no in no way repugnant to the existing criminal procedure laws. Before adverting further, let us understand the “Draft Rules of Criminal Practice, 2020.” It has provided for the following important points: - 1. Body Sketch to accompany Medico-Legal Certificates, Post-mortem Report and Inquest Report. 2. Photography and Videography of Post-mortem in certain cases. 3. Spot Panchnama of the place of occurrence shall also contain a Site Plan indicating various details such as place where was body was found, source of light, elevation of structures etc. 4. The accused is to be supplied with statements of witnesses recorded under S. 161 and S. 164 of the Code of Criminal Procedure, 1973 (in short, “CrPC”) along with the documents under S. 173, 207 and 208 of CrPC. 5. The Order framing charges shall be accompanied by a formal charge in Form 32, Schedule II of CrPC. 6. The deposition of witnesses shall be translated into English and will be read over mandatorily by the Presiding Office in Court and a free true copy of the same shall be supplied to the accused, the witness, and the prosecution on the very date of recording.7. The Record of Depositions shall indicate the date of the chief examination, cross examination and re-examination and can be done in question-and-answer format, if found necessary. Further, any objections while recording of evidence shall be reflected in the recording of the evidence and decided expeditiously. 8. The Exhibit Number shall further show the Witness Number after the Exhibit Number. 9. After framing of charges, the accused persons shall be referred to only by their ranks in the array of accused and not by their names. Even the Exhibits and the deposition of Witnesses shall be referred to by their numbers and not by names or other references. 10. Relevant portions of statements under S. 161 or 164 of CrPC or Exhibits used for contradicting or corroborating the respective witnesses shall be extracted and indicated in the deposition and admissible portion under S. 8 or 72 of the Indian Evidence Act shall be marked and extracted on a separate sheet and given an Exhibit Number. 11. Every judgment shall contain the details as provided in the Format appended to the Rules and contain the list of witnesses, exhibits and material objects. 12. All judgments shall contain the points for determination, the decision and its reasons and in case of conviction, it shall separately indicate the offence and the sentence therein. In case of acquittal, a direction shall be given to set the accused at liberty unless such accused is in custody in any other case. 13. Even in judgment, names shall not be used and only numbers and the nomenclatures indicated hereinabove shall be used. 14. Bails must ordinarily be disposed of within a period of 3 to 7 days from the date of first hearing and reasons for any such delay must be mentioned in the Order itself. Copy of the Order and the Bail Application must be furnished to accused on the date of pronouncement of Order itself. 15. More advocates should be appointed to assist the Prosecution. 16. Day to day hearing of all trials should be conducted and any delay in terms of Section 309 (1) of CrPC must be recorded. If the witnesses are in attendance, no adjournment shall be granted except for special reasons to be recorded to in writing. 17. Sessions cases should be precedence over all other work and no other work should be taken up on sessions days until sessions work for the day is completed. More about this shall follow in the next post.

For both adults and kids, there is an epidemic going around. And no, I'm not talking about COVID. I'm talking about ADHD (Attention Deficit Hyperactivity Disorder). All across the world, we are losing the ability to focus and pay attention. From 1997 to 2016, schoolchildren diagnosed with ADHD went from 3 percent to over 10 percent and it is still rising fast. From March 9th to March 30th of 2020, the proportion of teens diagnosed with ADHD rose 67 percent!Fortunately, more people are getting help for ADHD. Unfortunately, the most common form of treatment is to prescribe powerful, highly addictive stimulants with potentially serious side effects and even death. ADHD medications are Schedule II drugs, in the same category as cocaine, crystal meth and OxyContin. Worse yet, these drugs act as a crutch, robbing a person from developing their innate ability to pay attention and focus naturally. In this book, you'll learn how meditation can help children and adults focus and concentrate, calm their body and mind, and live happier and more peaceful lives. Hopefully, after learning the techniques in this book, we can turn that attention deficit into an attention surplus.Support the show (https://www.patreon.com/ToddPerel)

Dexedrine is a Schedule II drug that contains a high capacity for potential abuse. Dexedrine abuse can lead to dependence and addiction.https://recoverypartnernetwork.com/drug/stimulants/dextroamphetamine-addiction

Opioids are a class of drugs that act on opioid receptors in the brain. Signals sent to these receptors can block pain and lead to feelings of euphoria. Different types of opioids differ in a few key ways: the form of the drug (i. e. powder, tar, pill, liquid, etc.), how potent they are, how long their effects last and their potential for addiction.Morphine is a naturally occurring substance derived from the opium poppy plant often used to alleviate pain and other physical ailments. The U.S. classifies it in Schedule II, which means the federal government has determined that it has potential for misuse and dependence, but also has accepted medical use and can be prescribed to patients.https://drug-rehab-delray-beach.s3.amazonaws.com/ttc.htmlhttps://ttc-addiction-treatment.business.site/https://batchgeo.com/map/681ecafc169a47b7124bbe82fd1e775fhttps://batchgeo.com/map/7274655833ed942b86e23474567769e6https://goo.gl/maps/T6YAqq72Bhp9mXFHAhttps://goo.gl/maps/GXmvsx2h7iqsKSpq6https://goo.gl/maps/QCc8GLHhLUKUWcSy7https://t.co/RJRtlnt7bx#opioid-rehab-delrayhttps://t.co/A1qCrlVuaM#morphine-addiction-treatmenthttps://t.co/ygNYBpDSnL#substance-abuse-rehabhttps://earth.google.com/web/data=Mj8KPQo7CiExWTdScXFOT2NwLW11Um9BZUtkUjk5c24zc215czNzUHcSFgoUMEE2NzRGRkM2NjE4NTExNTgxMjEIt is classified as a Schedule I substance, which means the federal government has determined that it has no currently accepted medical use. However, heroin (diacetylmorphine) is available medically in some limited circumstances, particularly in Europe and Canada. In the U.S., almost all heroin comes from the unregulated market. Oxycodone and Hydrocodone are semisynthetic opioids derived from the opium poppy plant, are chemically similar to morphine and are used to treat acute and chronic pain.Oxycodone and hydrocodone are Schedule II substances, which means that the federal government has determined that it has accepted medical use is one of the most powerful opiate-based painkillers, used to treat chronic pain patients who have developed a resistance to other less powerful opiates such as morphine or oxycodone.Transformations Treatment Center14000 S Military Trail, Delray Beach, FL 33484FV9H+MC Delray Beach, Floridahttps://www.transformationstreatment.center/delray-beach-fl/drug-rehab/Morphine Detox in South FloridaFind Transformations on Google Maps!More Information:https://transformationstreatment1.blogspot.com/2021/01/morphine-detox-south-florida.htmlVideos:https://youtu.be/0k7LRjS34ichttps://vimeo.com/502269576Support the show (https://www.google.com/maps?cid=9720609399900639450)

Biden's current proposal aims to undo some of the previous social inequities caused by the War on Drugs by removing use and possession as a criminal offense at the federal level. This would be done by moving marijuana from a Schedule I to Schedule II substance. Take note that Biden's current proposal to decriminalize marijuana at the federal level is not the same as legalizing the drug. It would remain a controlled substance at the federal level. Biden's push to reschedule cannabis might be well-intentioned, but the move would allow the FDA to potentially impose strict regulations on the industry. For example, it could require that clinical trials be run to support claims that marijuana can be used to treat certain ailments, such as glaucoma or certain types of pain. The FDA would also be responsible for overseeing the manufacturing, packaging, and distribution of cannabis, and would likely impose strict requirements on producers in regards to tetrahydrocannabinol (THC) levels. Everybody around Joe Biden is in favor of cannabis legalization, but Joe Biden is not. It’ll get very interesting if we find ourselves in a Biden administration with a Democratic-controlled Senate because the question will be whether Nancy Pelosi and Chuck Schumer, as Speaker of the House and potentially Senate Majority Leader, are prepared to send to President Biden a legalization bill that he’s really not ready for. Show Notes: What Would a Joe Biden Presidency Mean for the Cannabis Industry? https://www.cannabisbusinesstimes.com/article/what-would-a-joe-biden-presidency-mean-for-the-cannabis-industry/ https://www.fool.com/investing/2020/09/20/joe-biden-and-cannabis-everything-you-need-to-know/ Joe Biden and Cannabis: Everything You Need to Know https://www.fool.com/investing/2020/09/20/joe-biden-and-cannabis-everything-you-need-to-know/ What Happens to Cannabis if Biden Wins? https://investingnews.com/daily/cannabis-investing/what-happens-cannabis-biden-wins/ Host: Josh Kincaid, Capital Markets Analyst & host of your cannabis business podcast. https://www.linkedin.com/in/joshkincaid/ Episode 569 of The Talking Hedge: Your Cannabis Business Podcast. ​Covering cannabis products, reviews, business news, interviews, investments, events, and more. https://www.theTalkingHedgepodcast.com Music Info: Song: Dark Trap Beats Hard Rap Instrumental | Gang | 2018Artist: LuxrayBeats Keywords: Hemp News, Weed News, Cannabis News, Marijuana News, Cannabis Business, Marijuana Business, Cannabis Industry News, Marijuana Industry News, Weed News 420, Talking Hedge Podcast, Cannabis Podcast, Marijuana Podcast, Business Podcast, CBD podcast, THC podcast, Cannabis Pitch Deck, Marijuana Pitch Deck, Marijuana Investment Deck, Cannabis Investment Deck, Cannabis Compliance, Cannabis Data, Cannabis Banking, Cannabis Investment, Pot Stocks, Cannabis Stocks, Weed Stocks, Marijuana Stocks, Cannabis Data, Marijuana Data, Cannabis Analytics, Marijuana Analytics, Cannabis Sales Data, Marijuana Sales Data Josh is not an investment adviser. The Talking Hedge is long gold and silver. Listeners should always speak to their personal financial advisers. --- Support this podcast: https://anchor.fm/talkinghedge/support

Biden's current proposal aims to undo some of the previous social inequities caused by the War on Drugs by removing use and possession as a criminal offense at the federal level. This would be done by moving marijuana from a Schedule I to Schedule II substance. Take note that Biden's current proposal to decriminalize marijuana at the federal level is not the same as legalizing the drug. It would remain a controlled substance at the federal level. Biden's push to reschedule cannabis might be well-intentioned, but the move would allow the FDA to potentially impose strict regulations on the industry. For example, it could require that clinical trials be run to support claims that marijuana can be used to treat certain ailments, such as glaucoma or certain types of pain. The FDA would also be responsible for overseeing the manufacturing, packaging, and distribution of cannabis, and would likely impose strict requirements on producers in regards to tetrahydrocannabinol (THC) levels. Everybody around Joe Biden is in favor of cannabis legalization, but Joe Biden is not. It’ll get very interesting if we find ourselves in a Biden administration with a Democratic-controlled Senate because the question will be whether Nancy Pelosi and Chuck Schumer, as Speaker of the House and potentially Senate Majority Leader, are prepared to send to President Biden a legalization bill that he’s really not ready for. Show Notes: What Would a Joe Biden Presidency Mean for the Cannabis Industry? https://www.cannabisbusinesstimes.com/article/what-would-a-joe-biden-presidency-mean-for-the-cannabis-industry/ https://www.fool.com/investing/2020/09/20/joe-biden-and-cannabis-everything-you-need-to-know/ Joe Biden and Cannabis: Everything You Need to Know https://www.fool.com/investing/2020/09/20/joe-biden-and-cannabis-everything-you-need-to-know/ What Happens to Cannabis if Biden Wins? https://investingnews.com/daily/cannabis-investing/what-happens-cannabis-biden-wins/ Host: Josh Kincaid, Capital Markets Analyst & host of your cannabis business podcast. https://www.linkedin.com/in/joshkincaid/ Episode 569 of The Talking Hedge: Your Cannabis Business Podcast. ​Covering cannabis products, reviews, business news, interviews, investments, events, and more. https://www.theTalkingHedgepodcast.com Music Info: Song: Dark Trap Beats Hard Rap Instrumental | Gang | 2018Artist: LuxrayBeats Keywords: Hemp News, Weed News, Cannabis News, Marijuana News, Cannabis Business, Marijuana Business, Cannabis Industry News, Marijuana Industry News, Weed News 420, Talking Hedge Podcast, Cannabis Podcast, Marijuana Podcast, Business Podcast, CBD podcast, THC podcast, Cannabis Pitch Deck, Marijuana Pitch Deck, Marijuana Investment Deck, Cannabis Investment Deck, Cannabis Compliance, Cannabis Data, Cannabis Banking, Cannabis Investment, Pot Stocks, Cannabis Stocks, Weed Stocks, Marijuana Stocks, Cannabis Data, Marijuana Data, Cannabis Analytics, Marijuana Analytics, Cannabis Sales Data, Marijuana Sales Data Josh is not an investment adviser. The Talking Hedge is long gold and silver. Listeners should always speak to their personal financial advisers.

Biden's current proposal aims to undo some of the previous social inequities caused by the War on Drugs by removing use and possession as a criminal offense at the federal level. This would be done by moving marijuana from a Schedule I to Schedule II substance. Take note that Biden's current proposal to decriminalize marijuana at the federal level is not the same as legalizing the drug. It would remain a controlled substance at the federal level. Biden's push to reschedule cannabis might be well-intentioned, but the move would allow the FDA to potentially impose strict regulations on the industry. For example, it could require that clinical trials be run to support claims that marijuana can be used to treat certain ailments, such as glaucoma or certain types of pain. The FDA would also be responsible for overseeing the manufacturing, packaging, and distribution of cannabis, and would likely impose strict requirements on producers in regards to tetrahydrocannabinol (THC) levels. Everybody around Joe Biden is in favor of cannabis legalization, but Joe Biden is not. It'll get very interesting if we find ourselves in a Biden administration with a Democratic-controlled Senate because the question will be whether Nancy Pelosi and Chuck Schumer, as Speaker of the House and potentially Senate Majority Leader, are prepared to send to President Biden a legalization bill that he's really not ready for. Show Notes: What Would a Joe Biden Presidency Mean for the Cannabis Industry? https://www.cannabisbusinesstimes.com/article/what-would-a-joe-biden-presidency-mean-for-the-cannabis-industry/ https://www.fool.com/investing/2020/09/20/joe-biden-and-cannabis-everything-you-need-to-know/ Joe Biden and Cannabis: Everything You Need to Know https://www.fool.com/investing/2020/09/20/joe-biden-and-cannabis-everything-you-need-to-know/ What Happens to Cannabis if Biden Wins? https://investingnews.com/daily/cannabis-investing/what-happens-cannabis-biden-wins/ Host: Josh Kincaid, Capital Markets Analyst & host of your cannabis business podcast. https://www.linkedin.com/in/joshkincaid/ Episode 569 of The Talking Hedge: Your Cannabis Business Podcast. ​Covering cannabis products, reviews, business news, interviews, investments, events, and more. https://www.theTalkingHedgepodcast.com Music Info: Song: Dark Trap Beats Hard Rap Instrumental | Gang | 2018Artist: LuxrayBeats Keywords: Hemp News, Weed News, Cannabis News, Marijuana News, Cannabis Business, Marijuana Business, Cannabis Industry News, Marijuana Industry News, Weed News 420, Talking Hedge Podcast, Cannabis Podcast, Marijuana Podcast, Business Podcast, CBD podcast, THC podcast, Cannabis Pitch Deck, Marijuana Pitch Deck, Marijuana Investment Deck, Cannabis Investment Deck, Cannabis Compliance, Cannabis Data, Cannabis Banking, Cannabis Investment, Pot Stocks, Cannabis Stocks, Weed Stocks, Marijuana Stocks, Cannabis Data, Marijuana Data, Cannabis Analytics, Marijuana Analytics, Cannabis Sales Data, Marijuana Sales Data Josh is not an investment adviser. The Talking Hedge is long gold and silver. Listeners should always speak to their personal financial advisers.

This week on the Pretty Girl Pill Club, Sophie and Rohnie take on a listener question about ADHD medications and substance abuse. We cover common misconceptions about ADHD, specifically about the psychostimulant medications commonly used to treat ADHD symptoms, which are regulated as Schedule II drugs by the United States Drug Enforcement Agency. Website: https://www.pgpcpod.com/ Instagram: https://www.instagram.com/prettygirlpillclub/ Twitter: https://twitter.com/pgpcpod Sources Substance Abuse and ADHD — Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD) https://chadd.org/for-parents/substance-abuse-and-adhd/ Other Concerns and Conditions with ADHD — Centers for Disese Control and Prevention (CDC) https://www.cdc.gov/ncbddd/adhd/conditions.html Coexisting Conditions — CHADD https://chadd.org/for-parents/coexisting-conditions-in-children/ Adults with ADHD, Overview — CHADD https://chadd.org/for-adults/overview/ Medication Management — CHADD https://chadd.org/for-adults/medication-management/ What is ADHD? Signs and Symtoms — CDC https://www.cdc.gov/ncbddd/adhd/facts.html#SignsSymptoms Amphetamine and Methamphetamine Differentially Affect Dopamine Transporters — Journal of Biological Chemistry https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631950/ Support the show: https://anchor.fm/pgpc/support Support the show via PayPal: https://bit.ly/3mg1If9 Thank you to our sponsors, PodGo, and Anchor. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/pgpc/support

"Drug Addiction"Wanna take it all back to where it startedLife of the partyRight where my heart atSoon as what I want come in, I say anything goesOn the road, cool, ridin' 'round with the top downNowhere to go to, decide that I'll just ride 'roundShe a drug abuser from a broken heart, oh, ohGot a bad addiction, I been druggin' hard all month longI'm in that Wraith, I ain't got nothin' but some residue on meI'm chasin' a check to the morningI'm in the trenches with smokers and steppers and lonersSomethin' more than one Schedule II on meMatter fact, just a convicted felon, I'm keepin' my weaponI'm pourin' more blood on that moneyOwe it all to the youngin who feel that he owe the onesPut addiction 'fore hunger

In this podcast I discuss the schedule of drugs and some other random drug facts! •Schedule of drugs https://www.dea.gov/drug-scheduling •Book I reference: https://www.amazon.com/Drugs-Society-Human-Behavior-Carl/dp/1259913864 Prevent access to drugs vs teaching someone the correct facts. •When schedule of drugs was created: -1970- War on Drugs began/ DEA (drug enforcement administration) was given more funding -1914- Harrison Act * 5 schedules were created - Schedule 1: Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: - heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote •1937- Reefer Madness, Targeting Hispanics with laws on marijuana - Schedule 2: Schedule II drugs, substances, or chemicals are defined as drugs with a high potential for abuse, with use potentially leading to severe psychological or physical dependence. These drugs are also considered dangerous. Some examples of Schedule II drugs are: - Combination products with less than 15 milligrams of hydrocodone per dosage unit (Vicodin), cocaine, methamphetamine, methadone, hydromorphone (Dilaudid), meperidine (Demerol), oxycodone (OxyContin), fentanyl, Dexedrine, Adderall, and Ritalin Barbiturates- CNS depressants, to use to reduce anxiety: sedative (Xanax- which is schedule 4, Ativan), Xanax and alcohol mixed would cause death due to short respiratory rate - Schedule 3: Schedule III drugs, substances, or chemicals are defined as drugs with a moderate to low potential for physical and psychological dependence. Schedule III drugs abuse potential is less than Schedule I and Schedule II drugs but more than Schedule IV. Some examples of Schedule III drugs are: Products containing less than 90 milligrams of codeine per dosage unit (Tylenol with codeine), ketamine, anabolic steroids, testosterone 18:14 - Schedule 4: Schedule IV drugs, substances, or chemicals are defined as drugs with a low potential for abuse and low risk of dependence. Some examples of Schedule IV drugs are: Xanax, Soma, Darvon, Darvocet, Valium, Ativan, Talwin, Ambien, Tramadol 24:30 Schedule 5: Schedule V drugs, substances, or chemicals are defined as drugs with lower potential for abuse than Schedule IV and consist of preparations containing limited quantities of certain narcotics. Schedule V drugs are generally used for antidiarrheal, antitussive, and analgesic purposes. Some examples of Schedule V drugs are: - cough preparations with less than 200 milligrams of codeine or per 100 milliliters (Robitussin AC), Lomotil, Motofen, Lyrica, Parepectolin 28:42- Opioids were a major cause of addiction in 1910, 1914 Harrison Act- putting taxes on drugs, Rockefeller drug laws 33:31- Alcohol and example of how it leads to wanting more. 36:24- Ketamine - strong antidepressant, horse tranquilizer Thank you for listening to my podcast! Follow me on Instagram! Living.wild.with.em

This podcast is provided by Ben Glass and Steve Emmert www.BenGlassReferrals.com - www.Virginia-Appeals.com   Granted Appeal Summary Case SHEA CURTIS, ADMINISTRATOR OF THE ESTATE OF MARY JO CURTIS v. CHRISTOPHER HIGHFILL, ET AL. (Record Number 190117) From The Circuit Court of Prince William County. K. Irving, Judge. Counsel Patrick A. Malone and Alfred A. Clarke (Patrick Malone & Associates, P.C.) for appellant. Michael E. Olszewski, Benjamin M. Wengerd, Rodney S. Dillman, and Julie C. Mayer (Hancock, Daniel & Johnson, P.C.) for appellees. Assignment of Error 1. The trial court erred by misinterpreting the standard for, incorrectly prejudging, and ultimately striking Ms. Curtis’ punitive damages claim, despite ample evidence in the trial record to support a finding by the jury of Dr. Highfill’s “willful and wanton” disregard for Mary Jo Curtis’ health and safety, given Dr. Highfill’s admissions that he had actual conscious awareness of the high risk of prescribing long-term Schedule II narcotics to his patient with bipolar disorder and a history of alcohol abuse, yet nonetheless wrote prescriptions on 144 separate occasions amounting to more than 7,000 opioid pills, and failed to ever examine her the last 52 times he wrote prescriptions in the 14 months before her death from an accidental overdose. www.courts.state.va.us/courts/scv/appeals/190117.pdf

In this episode Mark and Cody discuss Meth! It’s all about Meth and drugs in this episode. Personal experiences with drugs and other mind altering substances, people that the hosts know who suffer, and also some information on what Meth is and how it effects the body. We are on Spotify, Google Play, iTunes, Stitcher, iHeartRadio and wherever you listen to podcasts! Please review, and follow the show. Join us on our Facebook Page and Twitter and our Instagram page!  What is meth?Methamphetamine is a powerful, highlyaddictive stimulant that affects the central nervous system. Also known asmeth, blue, ice, and crystal, among many other terms, it takes the form of awhite, odorless, bitter-tasting crystalline powder that easily dissolves inwater or alcohol.Methamphetamine was developed early inthe 20th century from its parent drug, amphetamine, and was used originally innasal decongestants and bronchial inhalers. Like amphetamine, methamphetaminecauses increased activity and talkativeness, decreased appetite, and apleasurable sense of well-being or euphoria. However, methamphetamine differsfrom amphetamine in that, at comparable doses, much greater amounts of the drugget into the brain, making it a more potent stimulant.38 It also haslonger-lasting and more harmful effects on the central nervous system.39 Thesecharacteristics make it a drug with high potential for widespread misuse.Methamphetamine has been classified bythe U.S. Drug Enforcement Administration as a Schedule II stimulant, whichmakes it legally available only through a nonrefillable prescription. Medicallyit may be indicated for the treatment of attention deficit hyperactivitydisorder (ADHD) and as a short-term component of weight-loss treatments, but theseuses are limited and it is rarely prescribed; also, the prescribed doses arefar lower than those typically misused.The extreme psychological and physicaltoll that meth takes on the body makes it one of the most dangerous drugs onthe market. Meth deeply affects both a user’s brain and body, and thesesymptoms and warning signs are visible in a variety of ways.One of the first symptoms of meth abuseis a sudden loss of interest in areas of life that were once important to theperson. Hobbies, relationships, and career goals will all begin to take a backseat to getting and using meth. Initially, many people will attempt to hidetheir drug use, but the longer someone uses meth, the more prominent it becomesin their lives. Methamphetamine chemically alters how a user thinks and feels,which can make what was once a recreational drug activity a major life priority.People abusing or addicted to meth willexhibit a variety of behavioral and physical symptoms. Some of the most commonsigns of meth use include:HyperactivityTwitching, facial tics, jerky movementsParanoiaDilated pupilsNoticeable and sudden weight lossSkin soresRapid eye movementReduced appetiteAgitationBurns, particularly on the lips orfingersErratic sleeping patternsRotting teethOutbursts or mood swingsExtreme weight loss Another telling symptom of meth use is“tweaking” – a period of anxiety and insomnia that can last for 3 to 15 days.Tweaking occurs at the end of a drug binge when a person using meth can’tachieve a rush or high any longer. Tweaking can cause psychological sideeffects, such as paranoia, irritability, and confusion due to the desperationto use again. Tweaking from meth can also cause people to experiencehallucinations and become prone to violent behavior.Another sign that someone is using methis the crash phase. During this period, the body is deprived of the dopaminethat meth was previously supplying and causes extreme exhaustion. A crash canlast anywhere from 1 to 3 days and is characterized by long periods of sleep,intense drug cravings, and depression News:Sick. "Jealous of your daughter'sboyfriend? Help her inject him with a meth overdose, bury him in a shallowgrave, then marry her yourself. It's the West Virginia way"https://m.fark.com/goto/10625421/nypost.com/2019/11/18/dad-marries-daughter-has-sex-with-her-after-allegedly-killing-man-together-copDumbass. "Fifty pounds of meth?Shoot, a fella could have a pretty good weekend not being able to answer basicquestions in Bellingham with that"https://m.fark.com/goto/10686990/www.kiro7.com/news/local/50-pounds-meth-seized-during-bellingham-traffic-stop/3KS6WXMRS5EORL3LLWUMAVDumbass. "Take note, Farkers."Neither snow nor rain nor heat nor gloom of night stays these couriersfrom the swift completion of their appointed rounds" does not apply tometh"https://m.fark.com/goto/10679924/www.redandblack.com/athensnews/athens-couple-sentenced-to-federal-prison-for-mailing-meth-through/arScary. "'Meth-induced paranoia' +AR-15 + Oklahoma RV Park"https://m.fark.com/goto/10679524/kfor.com/2020/01/14/stray-bullet-narrowly-misses-garvin-county-couples-bed-after-neighbor-shoots-ar-Follow up "Meth = Kryptonite"https://m.fark.com/goto/10676153/pagesix.com/2020/01/11/hollywood-superman-suffocated-to-death-in-donation-bin-while-high-on-meth/%3FWeeners "Man high on meth beats 15cops while beating"https://m.fark.com/goto/10674114/www.wehodaily.com/news/man-high-on-meth-fights-off-15-police-officers-while-masturbating/%3Futm_sourDumbass "In today's "how inthe hell is this not a Florida story," Louisiana woman busted after hidingmeth in box labeled "dope""https://m.fark.com/goto/10671493/710keel.com/monroe-woman-busted-for-hiding-meth-in-container-labeled-dope/%3Futm_source%3Dfark%26utmDumbass "Advice to drivers: Don'tpark illegally in handicapped-accessible spot if you have meth in the car"https://m.fark.com/goto/10660942/www.omaha.com/news/crime/advice-to-drivers-don-t-park-illegally-in-handicapped-accessible/article_91Amusing "Man on scooter tries tooutrun police, all the while trying to ditch pills, heroin and meth. Chase endswhen scooter finally falls over"https://m.fark.com/goto/10658186/www.wishtv.com/news/crime-watch-8/man-on-scooter-leads-police-on-chase-arrested-for-meth-heroin/%3FuSick "Alaska man smuggles $400K ofheroin and meth inside rancid goat intestines. That's offal"https://m.fark.com/goto/10632292/news.yahoo.com/alaska-man-attempted-smuggle-400k-025929018.html%3Futm_source%3Dfark%26utm_medium%3Dw Support: With all that being said if you orsomeone you know may be addicted to meth and want treatment then please callthe American Addictions Center. Their number is 18889692341.

Following the May 10, 2017, Iowa Board of Pharmacy meeting, episode #7 discusses upcoming rule changes including connecting the Iowa Prescription Monitoring Program (PMP) with electronic health records (EHRs); the pharmacy technician’s role in pseudoephedrine dispensing and tracking; and changes to controlled substance regulations including partial fills of Schedule II substances with the passing of the Comprehensive Addiction and Recovery (CARA) Act in 2016. Please note that due to a change in the meeting schedule, the continuing education component will be delayed.

The U.S. Drug Enforcement Administration has placed the Syndros THC oral solution under Schedule II via FDA Approval.

The U.S. Drug Enforcement Administration has placed the Syndros THC oral solution under Schedule II via FDA Approval.

DEA Approves Syndros® THC Oral Solution as the new pharmaceutical drug has received approval for placement in Schedule II classification by the DEA.

ORIGINAL AIRDATE: February 11th, 1991 --- MacGyver is enlisted to help convince Earl Dent's parole officer that he's a good guy. MISSION: Earl Dent is trying to turn over a new leaf but his old gang keeps pulling him back in. MacGyver helps Earl tow the line and convince his parole officer that he means well. This week's highlights include: Methamphetamine (Narcotics) Methamphetamine in the United States is regulated under Schedule II of the Controlled Substances Act. It is approved for extremely limited pharmacological use in the treatment of attention deficit hyperactivity disorder and treatment-resistant obesity, but it is primarily used as a recreational drug. In 2012, approximately 1.2 million Americans reported using methamphetamine in the past year; 440,000 reported using the drug in the past month. Check out the article on wikipedia: https://en.wikipedia.org/wiki/Methamphetamine_in_the_United_States. Watch S6E15: "High Control" on CBS's website or check the alternative streamability of this episode here.

This is Entheogen. Talk about tools for generating the divine within. Today is January 7, 2016, and we are discussing A New Understanding: The Science of Psilocybin. Find the notes and links for this and other episodes at EntheogenShow.com. Sign up to receive an email when we release a new episode. Follow us @EntheogenShow on Twitter and like EntheogenShow on FaceBook. Thanks for listening. We discussed this film and interviewed its producer, Robert Barnhart back in August 2015 before the film’s release. Since then, the film has been released and you can rent or buy it on online. We’ve all had a chance to watch it again and we wanted to reflect on our impressions of the film. We’ll start with a quote from Alex Grey: "A New Understanding: The Science of Psilocybin puts an original face on psychedelics. Not the typical faces in the media of delusional drop-outs associated with drugs, but the faces of normal Americans, some suffering from the final stages of terminal cancer. After one dose of psilocybin the face of joy, relief and peace is nothing short of miraculous. A medical mystical miracle is in our midst, and this film beautifully describes the facts! Bravo to Robert Barnhart and all the production team, the courageous chemists, doctors and patients who are helping our society re-evaluate Psilocybin as a medicine for the Soul." ~Alex Grey Hofmann discovered LSD, creating the modern psychedelic movement; not many people know he also isolated and synthesized psilocybin, the active compound in magic mushrooms. Shutting down of research. Schedule 1. “No medicinal value, addictive” Kevin purports that Maria Sabina had given Albert Hofmann an “academic boner” over his successful synthesis of the active alkaloid in her magic mushrooms, psilocybin. “Throughout history, people have been able to have this mystical experience. The drug is a reliable way of getting one, but it's not about the drug, it's about the experience.” - Anthony Bossis Ann Levy’s son’s eulogy for her How does the experience help you confront death? “We’re all star stuff.” - Carl Sagan Bill Richards: 6 basic categories of a "core religious experience": 1. Unity 2. Transcendence of time and space 3. Noetic / intuitive knowledge 4. Sense of sacredness / awesomeness 5. Deeply felt positive mood / joy / peace / love 6. Ineffability / paradoxicality (difficult to put into words) Psilocybin and LSD as aphrodisiacs Why not? Why can’t we provide terminally ill people the relief these treatments offer? Brad: “word.” Wikipedia: List of Schedule I drugs and Schedule II drugs Rent or buy the film on Vimeo When you rent you can also watch DMT The Spirit Molecule The film’s website has a convenient “who’s who” of psychedelic researchers on the participants tab, with names, titles and photos, and a short bio when clicked

We are honored to be joined by Robert J. Barnhart, producer of A New Understanding: The Science of Psilocybin. For historical context, we review the groundwork laid in the 1980's by organizations such as the Multidisciplinary Association for Psychedelic Studies (MAPS) and Heffter Research Institute. Robert serves on the Boards of Directors of both organizations. Basic research began as early as the 1940's and continued through the '50's and '60's, until Nixon's Drug Control Act of 1970 when the highly promising research was extinguished. In the words of Roland Griffiths, "Can you think of another area of science regarded as so dangerous and taboo that all research gets shut down for decades? It’s unprecedented in modern science." Only as recently as in the last decade, thanks entirely to private fundraising by organizations like MAPS and Heffter, researchers have completed Phase I and Phase II studies. Plans for Phase III trials are on the horizon, and by some predictions, entheogens like psilocybin could be rescheduled to Schedule II (from Schedule I) perhaps as soon as 2020. At $10/pill an effective one-time-dose treatment like an entheogen might not be economically feasible or lucrative enough for today's pharmaceutical companies to pursue taking to market. But what about regular, ongoing "microdosing" of something like LSD? And moreover, the potentially vast application of entheogens toward the "betterment of well people" (in the words of Bob Jesse) would seem to be highly interesting to a pharmaceutical company. Robert recounts the story of how his would-be high school film project about the psychedelic experience may have serendipitously inspired his new film. In addition to supporting MAPS and Heffter, Robert recommends the Beckley Foundation in England. Also, write to Congress and talk to people about your own entheogenic experiences. For more about the studies, check out Anthroposophia: A different kind of love story: One woman's psilocybin experience by Sandy Lundahl. Thanks again to Robert Barnhart for joining us. Stay tuned for the release of A New Understanding: The Science of Psilocybin.

Special guest Abed Gheith, Rick and Morty writer and friend of the show, joins us to figure out the absolute best way to spend a single United States Dollar. Meanwhile Cullen admits to larceny on air, Bracket officially endorses the recreational use of a Schedule II controlled substance, and even sweet, dear Jesse talks about the crimes he has committed.

In general, how much education does a physician or psychiatrist get in med school around ADHD? Is there an impact on ADHD by such levels of education? ADHD stimulant medications are Schedule II drugs. How does that affect those who prescribe ADHD stimulant medications? Why is education and being in touch with your expectations important when seeking a professional who will be prescribing stimulants? Answers to these questions and more when we interview clinical psychologist Dr. Thomas E. Brown (www.DrThomasEBrown.com). If you are seeking a prescriber or have not found the right prescriber for you, this show is a must for you. Attention Talk Radio is the leading site for self-help Internet radio shows focusing on attention deficit hyperactivity disorder (ADHD) and attention deficit disorder (ADD), including managing symptoms of attention deficit disorder, adults with ADD, or adults who have children with ADHD. Attention Talk Radio, hosted by attention coach Jeff Copper, is designed to help adults and children (particularly those diagnosed with or impacted by attention deficit disorder or its symptoms) in life or business who are stuck, overwhelmed, or frustrated. It will help adults and children get unstuck and moving forward by helping to open their minds and pay attention to what works. Attention Talk Radio host Jeff Copper is an ADHD coach. To learn more about Jeff go to www.digcoaching.com.

Many states are legalizing medical marijuana, but leaving "next steps" in the dust. Patients, caregivers and researchers get stuck in the middle. Researchers have to walk a fine line in discovering the full potential of marijuana use, including cancer, seizures, arthritis, PTSD and brain illnesses such as dementia and Parkinson's. Only 6% of studies on marijuana analyze its medicinal properties. Sick patients in a state where medical marijuana is legalized often have to "fill their prescription" through drug dealers. It's like lawmakers are saying, "You want it and have proved the point that medical marijuana is beneficial. Now you...patients and medical community...figure it out." Expert guest Michael Bloom, Caregiving Without Regret™, and I discuss the impact on families, caregivers and patients. Dr. Sanjay Gupta, Emmy®-award winning chief med. correspondent, recently focused on U.S. federal laws that consider marijuana a drug with no medicinal value and serious scientists who say they're wrong. Shockingly, Marijuana is classified as a Schedule I controlled substance, grouped with heroin, LSD and PCP. Schedule II drugs -- still considered to have high abuse potential but with accepted medical uses and considered safe for use under medical supervision -- include cocaine, morphine and methamphetamine. That's right, federal law considers marijuana more dangerous than meth. Really? Listen live M-F 2:00 pm ET www.W4CS.com, Joni at www.JoniAldrich.com

Ritalin Addiction and Abuse is the subject of this Special Report by Siobahn Morse, the executive director of The National Institute for Holistic Addiction Studies. What is Ritalin? Ritalin is in a class of medications called central nervous system stimulants. They work by changing the amounts of certain natural substances in the brain. Ritalin is used as part of a treatment program to control the symptoms of attention deficit hyperactive disorder, also called ADHD. ADHD is when an individual has more difficulty focusing, controlling actions, and remaining still or quiet than other people who are the same age. Ritalin is also used to treat narcolepsy which is a sleep disorder that causes excessive daytime sleepiness and sudden attacks of sleep. What are the effects of Ritalin? If Ritalin is used as directed by a medical doctor, it has no side effects. However, when obtained illegally and abused by recreational users, its improper use can lead to dependence and eventually addiction. In the United States, Ritalin is classified as a Schedule II controlled substance, the designation used for substances that have a recognized medical value but present a high likelihood for substance abuse because of their addictive potential. What is Ritalin addiction and abuse? Ritalin has a high potential for drug abuse and drug dependence due to its pharmacological similarity to cocaine and amphetamine. The main abusers of Ritalin are teenagers and young adults, particularly those in colleges and universities who use this drug as a study aid. They may introduce this drug into their bodies through injection, snorting or smoking. Abusers often crush the tablets before using the powder. Some will mix it with cocaine and snort it while others smoke it together with illicit substances like marijuana. There are also those who mix the powder with water and inject it into the body. What are the side effects of Ritalin? In high doses for an extended period of time, the Ritalin user may experience paranoia, schizophrenia, and psychosis. Psychosis symptoms include: hearing voices, visual hallucinations, and/or ideation to harm the self or others. What are the withdrawal symptoms of Ritalin? Tiredness, panic attack, psychoses, irritability, extreme hunger, depression, and nightmares.       Click Here to Download a PDF version of this report.         Do you have more questions about drug abuse and addiction? Call our Toll-Free Recovery Hotline at 1-800-839-1682 and discover the best treatment options for you. Our experienced counselors are available 24 hours a day to take your call and get you the help or information you need. Our drug rehab center offers a unique and affordable holistic approach to addiction treatment. Our holistic addiction and treatment program has helped addicts from all over the United States, Europe and Canada overcome their substance addictions and achieve long term recovery. We treat the individual's specific needs, including working with families.   Find the Original Post with Downloadable Podcast and Drug Abuse Fact Sheet Here: Ritalin Addiction and Abuse

This episode covers the dismissal of the Premiere Medical Management liens in the amount of $70 million. The SCIF announces the resignation of Janet Frank. The California Nurses Association surveyed hospitals and determined there is a high risk of health workers being infected with H1N1 virus. The California DIR prevailed in a sexual harassment suit. The CWCI issued a Spotlight Report on Schedule II prescription drug costs. Utah "meth-cops" are having difficulty filing claims for injury resulting from methamphetamine exposure during arrests. Adam Dombchik, partner with the Personal Injury and Workers' Compensation firm Gordon, Edelstein, Krepack, Grant, Felton and Goldstein, has been named President of the California Applicants' Attorneys Association leadership team (CAAA) for 2009-2010.

ABSTRACT Backgroud: The World Health Organization Disability Assessment Schedule II (WHODAS II) is a new measure of functioning and disability that is conceptually compatible with the International Classification of Functioning, Disability, and Health (ICF). In contrast to other measures of health status, the WHODAS II is based on an international classification system, it is designed to be applicable across different cultures, and it treats all disorders at parity when determining the level of functioning. Objective: The general objective of this study is to investigate whether the WHODAS II – German version – is a useful instrument for measuring functioning and disability in patients with musculoskeletal conditions, cardiovascular and general internal conditions, stroke, breast cancer and depressive disorder. Specific objectives are to assess its psychometric properties reliability (internal consistency, Cronbach's Alpha), validity (factor analysis of dimensionality, convergent validity, discriminant validity), and sensitivity to change (effect size and standardized response mean), to determine to what extent the WHODAS II correlates with a traditional generic instrument for measuring Health Related Quality of Life, the SF-36, and to define its sensitivity to change after a rehabilitative intervention in relation to that other instrument. Methods: Patients with musculoskeletal conditions, cardiovascular and general internal conditions, stroke, breast cancer and depressive disorder participated. The patients completed the questionnaires WHODAS II and SF-36. After a rehabilitation treatment the same patients completed these questionnaires again in order to assess sensitivity to change. Analyses of measurement properties were conducted. Sensitivity to change was calculated by the effect size (ES) and standardized response mean (SRM). Results: Mean score on the WHODAS II is 21.98 (SD 14.32) for musculoskeletal conditions, 18.47 (SD 15.32) for internal conditions, 38.72 (SD 24.79) for stroke, 23.84 (SD 16.61) for breast cancer, and 44.56 (SD 18.95) for depressive disorder. High reliability is obtained. For the most part, the results of the scale replication confirm the determined six domains of the questionnaire. For the domain Activities, a clear distinction between work und household activities is apparent in both musculoskeletal and internal conditions. The correlations found in comparison to the SF-36 indicated that the WHODAS II (German version) measured indeed the expected constructs. The effect sizes of the WHODAS II Total Score range from 0.163 to 0.687 depending on the subgroup; effect sizes of the SF-36 summary scores from 0.025 to 1.395, respectively. In terms of patients reporting an improvement of general health status, effect sizes are accordingly higher (0.220 to 0.915 for the WHODAS II; 0.083 to 2.023 for the SF-36). Conclusion: The WHODAS II (German version) is a useful instrument for measuring functioning and disability in patients with musculoskeletal diseases, internal diseases, stroke, breast cancer and depressive disorder. It is reliable and valid and shows similar sensitivity to change scores as the SF-36 in the accordingly subscales.